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ABSTRACT
Glycogen has been extracted from human fetal livers ranging 
in age from 13 to 26 weeks. The average chain lengths have been 
determined by c<-amylolysis and periodate oxidation and the average 
exterior chain lengths by ^-amylolysis. The structures of liver 
glycogens from baboon, mouse, rabbit and several mature humans have 
also been determined. The absorption spectra of some glycogen- 
iodine complexes have been recorded and also glycogen values have 
been determined by the reaction with concanavalin A. The 
development of glycogen in the human fetal liver is discussed in 
relation to other mammalian species.
The activities of the enzymes glucose-6-phosphatase 
(D-glucose-6-phosphate phosphohydrolase), phosphoglucomutase 
(D-glucose-l,6-diphosphate : D-glucose-l-phosphate 
phosphotransferase), and phosphoglucoisomerase (D-glucose-6- 
phosphate ketol isomerase) in the human fetus have been studied.
The liver glycogens from four cases of suspected glycogen 
storage disease have been isolated and the structures determined 
as previously described. An electrophoretic and chromatographic 
study has been made of sugars in the urine of another case, where 
the patient lacked several intestinal enzymes.
The action of glucamylase and a commercial amyloglucosidase 
preparation ("Diazyme") on glycogen has been examined. The 
glucamylase and ^  -amylase limit dextrins of glycogen have been 
isolated and their average chain lengths determined.
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INTRODUCTION
Although Bernard isolated glycogen from dog's liver
more than 100 years ago, no detailed structural analysis was
(2)undertaken until the 1920*s when Karrer and Haworth and his
coworkers investigated the méthylation and acétylation of
the polysaccharide.
Prior to this it was known that glycogen was a glucose 
(4)
polymer, which could be enzymically degraded to a reducing
sugar and a mixture of dextrins by diastase, saliva and
(5)pancreatic juice. The exact nature of the linkages between
the D-glucose units had no significance until the ring structure 
of D-glucose and other monosaccharides had been postulated and 
proved.
(1)In mammalian tissues glycogen occurs in liver, skeletal
m u s c l e , p l a c e n t a l  t i s s u e , s u r f a c e  epithelial cells,
intestinal mucosal c e l l s , b r a i n , c a r d i a c  m u s c l e , a n d
k i d n e y . M a n y  other organisms contain glycogen, for example
y e a s t , f u n g i , i n s e c t s  and some bacteria such as
(15 )Escherichia coli. Certain plants such as Zea mays also
contain a polysaccharide possessing the characteristics of 
g l y c o g e n . A l t h o u g h  chemically indistinguishable from 
glycogen, their administration to rabbits, dogs and humans has 
been found to cause an increase in urinary loss of carbohydrate,
/ -J o \
although the blood carbohydrate levels remain constant.
Evidently they do not possess the same physiological characteristics
(19)as the mammalian glycogens. Sumner and Somers refer to
them as "phytoglycogens", but it has been suggested that
because of their botanical origin they should be considered as
highly branched amylopectins.
Conclusive proof that glycogen was a glucose polymer came
initially from Kulz and Borntrager, who compared the physical
properties of authentic glucose and the sugar obtained from the
acid hydrolysis of glycogen, and found them to be identical.
(2)
Méthylation and hydrolysis studies by Karrer and Haworth,
Hirst and Webb provided further evidence of the constitution
of the polysaccharide. Karrer also noted the similarity in
chemical behaviour between glycogen and starch.
There are several properties common to the three very similar
glucosans, i.e. glycogen, and the starch fractions, amylose and
amylopectin. All three show a high dextro-rotatory power in
aqueous solution, the specific rotation normally being in the
region +I9I - + 199 .(^^^22) molecular weights are in
the region 10^ - 10^, these values being average. Many samples
of these polysaccharides have been shown to be polydisperse when
examined in the ultracentrifuge. Smith and his coworkers have
also demonstrated this heterogeneity by electrophoresis on
(24)
glass-fibre paper*
The infrared spectra are also very similar* In the range 
730 - 960 cm. ^ the three polysaccharides show peaks at 928±3,
é>
838±3 and 760-2 cm.“^ The peak at 838 cm."^ is
characteristic of oC - linked D - glucopyranose units, and the
two other peaks are characteristic of D - (1-^4) - linked
(26)
glucans.
A reaction which serves to distinguish between the three 
polysaccharides is the formation of coloured complexes with 
iodine. Glycogens react with iodine solutions to give a 
reddish-brown complex, the absorption maximum usually occurring 
in the region 420 - 490 • The amylopectin-iodine complex
is again reddish, having a A at 530 - 540  ^(^7)
The colour given by amylose varies with the degree of 
polymerisation (DP). Very short chains of amylose have a 
X  max about 490 nyL^ but these are usually regarded as
degradation products, or intermediates in the synthesis of
a
(28)
(28 ) _____
amylose. True amylose has a much higher DP and gives 
blue colour with iodine. The value of A  is 6OO - 645/7?/^
max /
It is known that the staining properties of D - (1-^ 4) -
linked glucosans arise from the fact that the D - glucose
(29 30)molecules are arranged in a helix, ’ 6 D - glucose units
forming one turn of the helix. The iodine molecule or complex
(31)iodide ion occupies the space of one turn of the helix.
Colouration is not observed until the D - glucose chain is
/ pO \
12 D - glucose units long , although some workers consider
that 18 D - glucose units are necessary. In the case of
7linear molecules such as amylose the absorption maximum of the
(28 33)
iodine complex increases as the chain length increases. *
(34)Manners and his coworkers have examined the absorption
spectra of glycogen- and amylopectin-iodine complexes, and
suggest that the greater colour intensity given by amylopectins,
and the difference in the values of \ between the twomax
compounds arises from the difference in interior chain length, 
and hence from the difference in B chain length
B
A chains - chains linked by the reducing group to 
another chain.
B chains - chains having A chains attached to them.
R = reducing group 
E = exterior chains 
The average B chain length in amylopectin is 26 and that in 
glycogen I6. Hence the B chains of amylopectin will contain 
a large number of helices of a suitable length (I8 D - glucose 
units) to accommodate the iodine molecules, whereas glycogen
will have relatively few. The compactness and consequent
impenetrability of the glycogen molecule is suggested as an
additional factor which hinders complex formation. No
correlation between the chain length of the glycogens and
X  or the extinction coefficient (E ) was noted in  ^ max max
aqueous solution, but on addition of 23% or 30% saturated
(35)ammonium sulphate an increase in E^^^ and an approximate
correlation of average chain length (CL) with X  was noted*max
(35)Schlamowitz used a large excess of glycogen when making these
measurements and reported a correlation between E and CL.max
/ )
Manners and Archibald consider the periodate oxidation used
by Schlamowitz to determine CL values to be inaccurate (CL values
given were in the range 20-23 D-glucose units) and could not
(34)
repeat Schlamowitz*s results.
Potentiometric titration data have been studied by Bates,
(37)French and Bundle , who reported that the affinity for iodine 
varies directly with CL for starches, and that glycogen has a 
very low iodine affinity. Anderson and Greenwood have
improved the technique and report that the iodine-binding power 
of glycogen is about ^/lO that of amylopectins. Only an 
approximate relationship between iodine-binding power and exterior 
chain length (ECL) could be deduced.
Glycogen will form complexes with several proteins but
one in particular, concanavalin A, a globulin extracted from
9j a c k - b e a n s , h a s  been used to distinguish glycogens from
(4l)amylopectin and amylose. Glycogens give a precipitate with
solutions of this protein, and the resulting turbidity can be
measured spectrophotometrically. Neither amylose nor amylopectin
give a precipitate. Since the precipitation occurs most readily
with short-chain glycogens and yd - limit dextrins, (the molecules
remaining after the enzyme yf- amylase has removed the outermost
chains from glycogen molecules) it was suggested that the reaction
causing precipitation occurs in the interior of the glycogen
molecule. Méthylation or periodate oxidation decreases the
reaction with concanavalin A markedly, which indicates that the
hydroxyl groups are also involved in the reaction. Manners and 
(42)
Wright have examined 4? polysaccharide samples and report an
approximately linear relationship between the degree of branching
and the turbidity produced. They have suggested that there are
fundamental structural differences between glycogens and
amylopectins,as even amylopectins of the same branching
characteristics as some glycogens fail to react with concanavalin A.
Studies on the chain lengths and types of linkages present in
glycogens were originally based on the classical chemical methods
(43)of méthylation and periodate oxidation. Haworth and Percival 
obtained evidence of the o< - (1—^4) - linkages in glycogen by 
isolating a disaccharide from methylated glycogen. On oxidation 
and méthylation this disaccharide gave methyl octa-O-methyl- 
maltobionate. This proved that glycogen contained c/- (1 — ^ 4)-linked
/o
D - glucose units* The structure of the original disaccharide 
was CH^O/ie. CHjOMe
The same workers isolated 8.9% of methyl tetra-O-methyl-D- 
glucopyranoside from the methanolysate of methylated glycogen. 
Since this derivative can be formed only from the non-reducing 
end-group of a chain of o^-(l— >4)-linked D - glucose units, they 
were able to calculate an average value for the chain length 
(12 D - glucose units) of glycogen. The work of Bell 
supported the findings of Haworth and Percival. Bell also 
reported the presence of 2,3,8-tri-O-methyl-D-glucose and a 
di-O-methyl-D-glucose in the acid hydrolysates of methylated
(47)
rabbit and fish liver glycogens. The di^derivative was
later shown to be a mixture of 2,6- and 2,3-di-O-methyl- 
JD - g l u c o s e s . T h e  presence of the 2,6- derivative can be 
interpreted as an indication either of the presence of anomalous 
- (1— >3) - linkages, or of incomplete méthylation of the 
glycogen molecule.
(49)
Haworth and Hirst postulated a laminated structure for
glycogen in 1937, basing it on the discovery of the high molecular
hyl- 
(47)
weights of g l y c o g e n s , a n d  of the presence of 2,3-di-O-met
D - glucose in the acid hydrolysates of methylated glycogens.
11
which arose from the oC - (1—^6) - linked branch points.
1 R = reducing group 
^  - (1 — 6 ) -linkage
1
:
R
In the laminated structure each chain was considered on average
to be 12 D-glucose units long and linked to C-6 of a glucosyl
residue in the chain below.
(51)Staudinger put forward a comb-like structure, which
allowed for the chemical evidence and also accounted for reports, 
later disproved, that the glycogen molecule was spherical.
>/ . \/ \V /< /^  •
R = reducing group 
-> = (xT - (1-^ 6)-linkage
Both formulae explained the lack of reducing power of glycogen
(52)
previously attributed to the effect of the alkaline
extraction medium on the reducing group^ in the, presence of cur. 
CH^OH
- O
H^Oh
CH^OH
OH
OH
O
/2
(53)In 19^1 Meyer and Fuld postulated the tree-like structure,
which is now commonly accepted. They based this upon the fact that 
^  - amylase catalyses the stepwise hydrolysis of alternate 
oC - (1 —^ 4) - linkages in glycogen, thus releasing maltose, 
and leaving a high molecular weight dextrin ( yS - dextrin) since 
it cannot hydrolyse or by-pass the cxT- (1— ^6) - linkages at the 
branch points.
R = reducing group 
-> = cxC-(1^6)-linkage
From an analysis of the structure of the yf- limit dextrin they
put forward the total glycogen structure shown above as being the
only one which corresponded with their findings. In fact all three
structures would have behaved similarly with - amylase. Meyer
and Bernfeld had already established that amylopectin had a
randomly branched structure by successive treatments with jS - amylase
( 55 )followed by a yeast enzyme preparation. The yS - limit dextrin
obtained by the action of - amylase on amylopectin gave D - glucose 
and a second limit dextrin on treatment with the yeast enzyme.
The second dextrin was degraded further by - amylase to give a 
third limit dextrin, which gave a reddish-brown stain with iodine.
/s
These results were consistent with the randomly branched structure*
Structures of the laminated or comb type would have yielded a
second dextrin that gave a blue iodine complex and was completely
degraded by amylase to maltose. It was found that the same
yeast enzyme degraded some of the interchain linkages of glycogen 
(
yf - dextrin and this was taken as proof that the glycogen
molecule resembled amylopectin in its branching characteristics.
(57)Illingworth, Larner and Cori obtained more rigorous proof of
the structure of glycogen by a similar method, substituting 
phosphorylase and amylo - 1,6 - glucosidase for y6 - amylase and 
the yeast enzyme.
Partial acid hydrolysis has been used to support the evidence 
for the existence of oC- (1— ^4) — and - (1— ^6) - linkages in
/ cO \
glycogen. Wolfrom and his coworkers acetylated the sugars
obtained from a partial acid hydrolysate of rabbit liver glycogen
and isolated j6 - isomaltose octa-acetate. Bacon and Bacon
isolated isomaltose by partial acid hydrolysis followed by carbon-
( 59)celite chromatography, and, using the same techniques. Peat,
Whelan and Edwards have degraded baker *s-yeast glycogen to
D - glucose, maltose, isomaltose and panose. Wolfrom and 
Thompson have isolated isomaltotriose, showing that a small
number of chains are attached by - (1—:^6) - glucosidic linkages 
to adjacent D - glucose residues.
/f
CH.OH
OH.OHCHxOH
The same workers also isolated 0.001% nigerose from the 
hydrolysate, suggesting the presence of anomalous - (1^3) - 
linkages. This supports the first interpretation of the isolation 
of 2,6-di-O-methyl-D - glucose by Bell.^^^^ Smith and coworkers^^^^ 
have produced more evidence in support of this by isolating 
D - glucose after periodate oxidation, reduction and hydrolysis 
of glycogen. Neither of these more recent findings can be 
considered conclusive however, as the nigerose could arise from 
acid-catalysed transglucosylation from maltose and the
D - glucose from incomplete periodate oxidation. D - galactose 
has been isolated from an acid hydrolysate of chick liver glycogen, 
when the chicks have been fed on a high galactose diet.^^^^
Periodate oxidation has been used as a method for determining 
the average chain length of glycogen and also for characterisation 
of the linkages between the D - glucose units. Formic acid is 
liberated only from the non-reducing end-groups in the glycogen 
molecule.
/5
OH I O H ,
MO/
OH
CHtOH CM&OH
>  H.COOM+ C.HO
CMo C h o  CHO
By titration of the formic acid with alkali, a measure of the 
number of non-reducing end-groups is obtained, and the CL can be 
calculated from this. Hirst, Jones and coworkers used the
method to assay a number of glycogens and found the CL values 
corresponded fairly closely with those determined by méthylation. 
Potter and Hassid modified the conditions, substituting
sodium metaperiodate for the potassium salt and reducing the 
temperature and reaction time. This ensured against over­
oxidation but unfortunately resulted in incomplete oxidation.
Abdel-Akher and Smith (22) increased the oxidation time to 80 hr.
and obtained excellent agreement with the results of Halsall,
Hirst and Jones. (65) Manners and Archibald (68) suggest 7 - 1 0
days for complete oxidation using Potter’s method and 300 - 400 
hr.^^^^ for the method of Halsall, Hirst and Jones.
Some information can be obtained from periodate oxidation 
alone. Formic acid can only be produced if the hydroxyl groups 
on C-2, C-3 and C-4 are free (see diagram on p. /5 ). The fact 
that the amount of formic acid produced is very small indicates 
that normally one or more of these hydroxyl groups is involved 
in the chain linkage, and that (1 —^ 6)- linkages do not form the
/é
main type of linkage• The large consumption of periodate shows
that there must be a great number of adjacent pairs of hydroxyl
/
groups, i.e. if the main linkages are (1-^2) or (1-^4) :
ON
HOi
OH / OH
More precise information on the inter-chain linkages can be obtained
by acid hydrolysis of the oxidised polysaccharide, (70) preferably
after reduction with hydrogen, Raney nickel or sodium borohydride, 
as the yields of hydrolysed fragments are greatly increased»
The fragments normally consist of polyols, although D-glucose will 
be obtained if ( 1 3 ) -linkages are present. Treatment of 
glycogen in this way results in the following reactions:
(62)
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Measurement of the ratio of glycerol to erythritol gives an
estimate of the ratio of terminal to non-terminal D-glucose
(62)residues, i.e. the value of the average chain length. Smith 
found a value of 10 D-glucose units by this method.
In more recent years enzymic degradation methods have been 
used to elucidate the structures of glycogens. The three groups
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of enzymes which will degrade glycogens are the - and -amylases,
( <x -1,4-glucan 4-glucanohydrolase and -1,4-glucan maltohydrolase)
phosphorylase, ( (x. -1,4-glucan:orthophosphate glucosyltransferase)
and debranching enzyme (starch 6-glucanohydrolase)•
-amylase has been prepared in the crystalline form
from barley, wheat, sweet potato and soya-bean. Even pure
preparations contain a trace of Z-enzyme, which, if the preparation
is used in high concentrations with glycogen, results in an
abnormally high production of maltose. Z-enzyme, which is found
in many plants, was originally thought to possess ^-glucosidase
(72 73)
( -D-glucoside glucohydrolase) activity, ’ since it 
hydrolysed ^-(1-^2), ^-(1^^3)-* p -(1 -^4)-, and (^-(1—>6)-
(74)glucosidic linkages. It is now thought to act as an - amylase, 
causing random hydrolysis of a few o< -(1 —^4)-glucosidic linkages 
in the interior of the glycogen molecule, thus rendering it 
susceptible to further (3 -amylolyis.
( 75 )With amylose ^-amylase gives a 70-80% conversion to maltose,
instead of the expected 100% conversion. This must be due to the
presence of a small number of anomalous linkages in the amylose
molecule. Non-terminal phosphate groups have been shown to
constitute a barrier to the action of ^ - a m y l a s e . B a n k s  and
Greenwood have shown that the anomalies are not due to phosphate
groups, since pre-incubation of amylose with phosphatase does not
( 77 )increase the -amylolysis limit. Addition of Z-enzyme to
the ^-amylase preparation results in complete conversion to
13
(75) It was originally thought that Z-enzyme hydrolysed 
(75)
maltose*
the anomalous linkages, but with the discovery that Z-enzyme
activity was an (X -amylase activity, the increase in the jS -amylolysis 
limit was seen to be caused by the random hydrolysis of a few of the 
(?(-(1-^ ^ )-linkage6. In many cases this would remove the barrier
to further -amylolysis
G- G-
action ceoises 
hef^ uÀ-irh pou-c, 
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Recently the anomalous linkages have been found to be ^ - ( 1 —^6)- 
glucosidic inter-chain l i n k a g e s * T r e a t m e n t  of amylose with 
yeast isoamylase, an enzyme that hydrolyses o(-(1-v 6)-glucosidic 
linkages, followed by -amylolysis resulted in an increased 
production of maltose. Manners considers that there are not more 
than one or two branch points per molecule of amylose
20
O  O
c r "
Pure ^-amylase cannot bypass the (X -(1— >6)-linkages in 
glycogen and amylopectin and hence a high molecular weight dextrin 
is left. The conversion to maltose is 40-50% for glycogen and 
50-60% for amylopectin. Amylopectin gives a larger conversion 
since its ratio of exterior to interior chain lengths is slightly 
larger than that of most glycogens. In all cases short "stubs" 
are left attached to the inner chains after the action of
^ -amylase. Meyer considers that the stubs are one or two
5
(80)
( 79 )D-glucose units in length, whereas Peat,Whelan and Thomas state
that the A chain stubs are two or three D-glucose units long.
This was based on the formation of maltose and maltotriose by the 
action of 7^ -enzyme on amylopectin 0 -dextrin. "R -enzyme is a 
debranching enzyme which occurs only in plants. It will hydrolyse 
the (X -(1— > 6)-glucosidic linkages in the plant polysaccharide 
amylopectin, but has no action upon glycogen or glycogen limit 
dextrins. ^
_ _  prooLuc^d
ac-Hon of
nna.liz>se. R  —e n z i/f  m e
p ro d u ce d i b(j 
acbchn. of
2/
/ o p \
Manners considers that the attack on the B chains will be
similar, resulting once more in stubs of 2 or 3 D-glucose units. 
French has advanced the theory that the B chain stubs are only 
one or two D-glucose units long, which would bring the average 
length of the stubs down from 2*5 to 2 D-glucose units. This work 
was based upon the action of /3-amylase on branched substrates, 
whose structure after -amylolysis could be easily determined.
® O — O   ^ O — o — o —  ^ o —   ^o — o  o — o —
a O — O  A0 — 0  A 0 - 0 - 0  . 0 —0
® 0 - Q ---- ® 0 - 0 — Q   ® C)-0— -
'^o—0-0 0^-0-6  ^o-o-o-o
(ase -  T€S '/S'bafil' n o n - r-es-'( sd an  ir
drrnn^ennenfs . CKmo.n(^-err)enJrS,
A
/4 =  /4 chcLcn ,
-> =  é)-~^iucos) die
6 = 6
The action pattern of CX -amylase is essentially a random one, 
involving the hydrolysis of X -(1 4)-glucosidic linkages to
produce finally maltose and branched oligosaccharides of DP >  4. 
With low concentrations of enzyme maltose, maltotriose and 
6^- a  -maltosylmaltotriose are formed.
-I
With higher concentrations of enzyme a second stage of hydrolysis
occurs; the maltotriose is hydrolysed to give maltose and glucose
%
and the smallest dextrin produced is 6 - ^  -glucosylmaltotriose:
Panose has been observed in digests of Bacillus subtilis 
(X -amylase with amylopectin.
A
Manners and Wright^^^^ have recently developed a method for 
determination of the CL of glycogens, based on second stage 
cx -amylolysis. Measurement of the apparent conversion to 
maltose (P^ ,) can be statistically related to the number of branch 
points and hence to the number of end groups. This method has 
now been modified to enable Img. quantities of glycogen to
be assayed*
Muscle phosphorylase in the presence of inorganic phosphate
/ QQ Qq\
will hydrolyse 20-44% of the exterior chains of glycogen, ’ 
yielding D-glucose-l-phosphate and a limit dextrin ( -dextrin). 
On addition of amylo-l,6-glucosidase (starch 6-glucanohydrolase) 
the outermost branch linkages are hydrolysed, and the molecule 
rendered susceptible to further attack by the phosphorylase, 
which proceeds until more branch linkages are encountered. Thus 
the concurrent action of the two enzymes produces complete
hydrolysis of the glycogen* The products are D-glucose-l-phosphate 
from phosphorylase action and D-glucose from the action of 
amylo-l,6-glucosidase.^^^*^^^ The relative proportions of the 
products gives a measure of the number of branch linkages and hence 
the The structure of the (j> -dextrin was originally thought
to contain A chain stubs of one D-glucose residue and B chain stubs
(90)
6
of 6 D-glucose residues
Whelan (92,93) Illingworth (9^,95) their coworkers
have modified the structure after finding that 1?. -enzyme liberated
maltotetraose on incubation with amylopectin (j) -dextrin*
(92)Also Whelan could find no evidence for single D-glucose unit
A chain stubs since no 6^- (X. -glucosylmaltotriose was obtained on 
'X -amylolysis. They suggested that the A and B chain stubs are 
4 D-glucose units long, giving a structure as shown below:
A
The values of the average chain length (CL) and average
exterior chain length (ECL) reported by various workers show that
most glycogens have a CL of between 10 and 14 D-glucose units and
an ECL of 7 to 9 D-glucose units. Results of méthylation analyses 
/Arrivai (43)
by Haworth and ooworkoro Bell and Hirst, Jones and
( )  — -
coworkers showed this variation in CL, although most of the
glycogens studied possessed a CL of 12 D-glucose units. Halsall,
Hirst and Jones obtained good correlation between CL's
determined by periodate oxidation and méthylation. Smith and
( 22)Abdel-Akher analysed 36 glycogen samples by periodate oxidation
and reported CL* s between 10 and l4 D-glucose units. Manners and 
(68)Archibald find the same variation. Of special note in this
latter paper is the CL of 11 D-glucose units for a fetal pig liver
glycogen ( [x]p+191*). Bell and Manners reported a CL of
13 D-glucose units for a fetal sheep liver glycogen, and Illingworth 
( AR \  _ _ _ _
and coworkers found a CL of 11*5 D-glucose units for a fetal
guinea-pig liver glycogen. Unfortunately the fetal ages of the 
animals were not recorded, but it can be seen that the CL values 
are within the range encountered in all other mammalian glycogens.
The percentage of maltose liberated by the action of ji -amylase 
is usually in the range 40-50%. For example Bell and Manners (^9) 
reported studies on 11 glycogen samples, whose percentage conversions 
to maltose range from 37% to 49%. The 37% conversion was obtained 
from Helix pomatia glycogen, which has a CL of 7 glucose units ——
well outside the normal range. The lowest % conversion for a 
mammalian glycogen was 4l% for a human muscle glycogen.
Warren and Whittaker (9^) have studied fetal goat liver 
glycogen through the period of gestation 95-146 days. They
observed no correlation between CL or ECL and the age of the fetus.
Most structures appeared to be normal, CL ranging from 12*1 to
15*7 D-glucose units and ECL from 8 to 12 D-glucose units.
After 130 days of gestation an increased susceptibility to
phosphorylase was noted. The liver glycogen from a mature goat
did not exhibit this increased susceptibility, but no data on
( 88 )new-born animals was given. Illingworth and coworkers
reported phosphorylase limits of 42*7$ 40.8 and 39*9% for fetal,
new-born and adult guinea-pig liver glycogens, but no fetal age
was quoted, and the results were not corroborated by tests on any
(97-99)more guinea-pigs. Several workers have reported that
glycogen in fetal guinea-pigs accumulates rapidly near term and 
decreases rapidly in the neonatal period, but Warren and 
Whittaker give no figures for this in their study on goats.
Another group of enzymes which degrade glycogen (to D-glucose 
and a limit dextrin) are the mould amyloglucosidases 
( X-l,4-glucan glucohydrolases)• They occur together with 
X-amylase, jS-amylase, maltase (maltose 4-glucohydrolase) and 
transglucosylases in such moulds as Aspergillus niger (100*101)
(it is known as glucamylase when obtained from this mould),
Rhizopus delemar,d02) Aspergillus oryzae, and Clostridium 
acetobutylicum.(10^) Barker and Carrington (105) reported the 
presence of an enzyme in A. niger ’*152", which produced D-glucose 
on incubation with starch. Barker and Fleetwood (100*106) 
developed the study of this enzyme using A. niger NRRL-530-1, 
and obtained an -amylase-free enzyme preparation which attacked 
only substrates containing an (X -D-(l — > 4)-glucosidic linkage at 
the non-reducing end of the molecule, e.g. maltose, starch and 
amylopectin. The action on amylopectin ceased at 60% conversion, 
when branch points were encountered, although on prolonged incubation 
the traces of o( -amylase rendered the molecule susceptible to 
further hydrolysis. A similar action on glycogen was noted®
This work confirmed the observations of Kerr and coworkers, 
who used the same strain of A. niger.
Pazur and Ando (1^7*108) purified a commercial
amyloglucosidase ("Diazyme") and studied its action on starch, 
amylopectin, amylodextrins and D-glucosyl oligosaccharides 
containing -(1 -^4)- and -(1—^6)-linkages® They found that 
the purified enzyme hydrolyses X - ( l —^4)- and, ^ -(1 —>6)-linkages, 
the former being hydrolysed more quickly. This results in almost 
complete hydrolysis of starch and amylopectin. The enzyme source
I
was again A. niger, but the strain was not specified.
The amyloglucosidase from Rhizopus delemar has been studied 
by Phillips and Caldwell (^^^) Tsiyisaka and Fukumoto,
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who respectively report 92% and 100% conversions of glycogen to 
D-glucose. Both this enzyme and the corresponding one from
A.oryzae have been obtained in crystalline form. Hopkins
and Kulka jj^ ve found an amyloglucosidase in Saccharomyces
diastaticus which can bypass the X - ( 1 6 ) -linkages of amylopectin 
^-dextrin to produce a trisaccharide.
The function of glycogen as the body’s reserve carbohydrate 
has long been known. The method of degradation of glycogen to 
blood sugar (D-glucose) was for a long time thought to be by 
hydrolysis, catalysed by an amylase-type enzyme. Glock in 
1936 reported an amylase in liver, which did not have a
random action and produced maltose, which was further hydrolysed 
to glucose in most animal tissues. Parnas at about the
same time showed that glycogen degradation required inorganic 
phosphate, and Cori and Cori (^^7,ll8) identified the hydrolysis 
product as D-glucose-l-phosphate. Phosphorylase, ( X -1,4- 
glucan: orthophosphate glucosyltransferase) the enzyme which 
catalyses the degradation of glycogen, has now been obtained pure 
from several muscle and liver s o u r c e s . 124) catalyses
the reversible reaction,
^  - G/ucose-I -  fDhosphate^ ^ PQ^
( polijsacchande
prcrner )
which led workers to believe that phosphorylase was responsible 
for the synthesis and degradation of glycogen. The synthetic
action requires a primer molecule, glycogen or amylopectin being 
the most efficient; amylose is less so. The corresponding plant 
enzyme, P-enzyme, has a less stringent primer requirement, needing 
only 4 ( 1 4)-linked % -D-glucose r e s i d u e s . M a l t o t r i o s e  
is a very poor primer, but maltotetraose, maltopentaose, 
maltohexaose, amylose and amylopectin make increasingly efficient 
primers.
The action of pure phosphorylase yields straight chains of 
- ( 1 4 ) -linked D-glucose units, whereas liver homogenates 
synthesize both -(1 ^ 4 ) -  and x-(l —^6)-linkages, This is due 
to the presence of a branching enzyme in liver. The resulting 
structure is glycogen-like in the latter case; in the former it 
approximates to an amylose-like structure. Similarly the 
degradation of glycogen by pure phosphorylase results in a 20-44%
(88 89)conversion * to D-glucose-l-phosphate and a ^ -dextrin, whose
structure is shown on p. ^3. Liver preparations contain a 
debranching enzyme, amylo-1,6-glucosidase, which catalyses the 
hydrolysis of the (X -(1 6)-linkage between a single D-glucose
unit and a B chain in the <j> -dextrin, and renders the molecule
susceptible to further phosphorolysis.
Broojn (94)
Brown-, Illingworti^and Cori have reported the presence
of an oligo-1,4-> 1,4-glucantransferase activity in rabbit muscle
closely associated with the amylo-1,6-glucosidase. Maltosyl or
maltotriosyl units are transferred by this former enzyme to other
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branches of the ^ -dextrin molecule. This results in further 
branches with a single D-glucose residue attached by an
o{ -(1— >6)-linkage:
Amylo-1,6-glucosidase will cleave this new branch linkage.
arid AhdiuKah Qraion and ^ ‘”(95)
Abdullah- and Whelan and Brown and Illingwofth have since
jointly reported that this system will debranch glycogen itself, 
as well as the ^ -dextrin obtained from it by phosphorylase action.
As can be seen from the diagram, the oligo-1,4 1,4-glucantransferase
is capable of producing a structure resembling the (j> -dextrin 
structure put forward by Cori and Larner.^^^^ The debranching of 
glycogen by the transferase and amylo-1,6-glucosidase system can 
thus be readily understood©
Muscle phosphorylase occurs in two forms— an active form a 
and an inactive form b , which requires the addition of adenosine 
monophosphate (AMP) for activation© They may be interconverted 
as follows:
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(lai)
PR e n z y m e  . u
phosphorLjlas-e. ^ ------------->  c7 phosphorLjIase b
(phospho^e- 
'rem o\rLnp
e n z y m e .  ')
2  pho5phor(jlase jp_ -f - ^ / I T P
-ff*
M n  a n c (
■>
pho^ph.orcj(as-e b 
h'cnas-c C ; phosphorijlas'-e 
phos p pLoir~pn s - f e r a s e ^  
p h o s p h o iT L jla s '- ^  ^  -p ^  A T )P
ATP = adenosine triphosphate 
ADP = adenosine diphosphate 
Muscle phosphorylase molecules are highly complex. The b form 
is a dimer containing in its protein chains the following amino 
acid sequence:
GLuCt^ 2^.^  (130)
Lys - Glutamine - lieu - Ser - Val - Arg
Activation of the enzyme involves addition of inorganic phosphate
to the serine group to form phosphoserine, and the formation of
/ 1 p Q \
a tetramer from two molecules of phosphorylase b.
The b form contains two binding sites for AMP, whereas the
a form has four.
5/
Serene Senne
X X
Fhospho  -  
serine
FhosphjO — 
Serine.
^ - L  P yr.p .
-----------
F h o s p h o  - P h o s p h w  -
serene senne
Phosphorylase b Phosphorylase a
X = binding site for AMP 
, pyr.p, = pyridoxyl 5 -phosphate.
Both forms have been shown to contain pyridoxyl 5-phosphate,
4 moles per molecule of the a form, and 2 moles per molecule of 
the b f o r m . T h e  function of the pyridoxyl 5~pbosphate 
appears to be that of a prosthetic group, i.e. its presence is 
necessary for the activity of the enzyme. Some doubt has been 
expressed as to whether it is a true prosthetic group, since its 
reduction by sodium borohydride does not affect the activity of 
the enzyme.^ ^
The liver phosphorylase is a very similar enzyme. It exists 
in an active form and an inactive one (dephospho-phosphorylase).
The latter form is not activated by like phosphorylase b,
but in the presence of Mg"^ , ATP and a liver enzyme, 
dephosphophosphorylase kinase, (ATP: dephosphophosphorylase 
phosphotransferase) its activity is restored.
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pK ospK oTry las’e  p ho spha tase  
( fp h o s p h o r y  lase p h o s p k u o
(9c f(V e  j ^ r r r u ----------------------------------- ^  dephosphophosphonjlQse
^ -----------------------
hncxsG. -t adenosLne-3^5 ^  p-
{cjjcJic^ phosphcx ire . 
as a  co fdc-to r^  0 3 / )
The main distinction between the muscle and liver enzymes is that
there is no molecular weight change during conversion of the liver
(135)enzyme.
In 1937 Leloir and Cardini reported the synthesis of
glycogen from uridine diphosphate glucose (ÏÏDPG) and a rat liver 
homogenate. Subsequently the enzyme concerned was found in rat 
m u s c l e , p i g e o n - b r e a s t  m u s c l e , a n d  rabbit brain.
The reaction is catalysed by an enzyme, UDPG-glycogen transferase 
(UDPglucose: #-l,4-glucan ^-4-glucosyltransferase), which 
catalyses the transfer of an cx -D-glucosyl unit from ÜDPG to an
acceptor molecule such as glycogen:
U D P G -  -V- phme.r-  ----------»  U E iP  -t- g U c o s y L - ( i X - 4 } - p r ( m e r
The donor molecule arises from the reaction
(m)
d t p  ■+- o^— 'D-G — i-P LVDPG- +  pyrophosphœhe
ÜDPG- hosphcn^ula^
(1>TR : — g tu co se ,- I—p h o s p n c ju fe  ari'oLy I t j  (
Starch,  ^- and ^-dextrine make poor acceptor molecules for the
(138) __
rat liver enzyme. Malto-oligosaccharides of DP 3""7 have
been tested as acceptors for the rat muscle enzyme and are also
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(142)very inefficient. Glycogen synthesis via the UDPG-glycogen
transferase pathway is now more favoured than synthesis via 
phosphorylase for the following reasons:
(a) The normal ratio of inorganic phosphate to D-glucose-l- 
phosphate at equilibrium in the phosphorylase reaction is 1:3, 
whereas Larner, Villar-Palasi and Richman have shown that 
glycogen synthesis occurs readily in normal and insulin-treated 
rat diaphragm muscle in conditions where this ratio was 300:1.
(b) The hormones glucagon and epinephrine stimulate glycogen 
breakdown only, although they produce this stimulation by increasing
(144)phosphorylase activity.
(c) Glycogen synthesis still takes place in certain glycogen 
storage diseases, where phosphorylase is absent.
(d) The biosyntheses of c e l l u l o s e , x y l a n  and 
(149)
starch are known to take place through nucleotide
intermediates, the general reaction being:-
UDPG + HOP GOR + UDP
(G = glycosyl residue)
The role of phosphorylase is now considered to be purely 
degradative.
UDPG-glycogen transferase is markedly activated by D-glucose- 
6-phosphate ^^39,150) i n s u l i n . T w o  forms of the
enzyme have been i s o l a t e d . O n e  form (D) was found to be 
dependent on D-glucose-6-phosphate for its activity and the other
form (I) independent. The two forms are interconvertible
dephospha-rc^ [cx±can ('^5, /5é.)
D  = ± I
/^T R -and  Mg d e p e n d  eat* p h os phanjlcu toon.
The branching enzyme amylo-1,4-> 1 ,6-transglucosidase has 
been studied by L a r n e r , w h o ,  using radioactive techniques, 
has shown that branching occurs when the exterior glycogen chains 
were between 6 and 11 D-glucose units long. Petrova has 
demonstrated an amylose isomerase in m u s c l e . I t  is 
distinctly different from the normal branching enzyme, since it 
can synthesize or degrade 0( -(1--^ 6)-linkages in glycogen^ or 
starch, although it produces glycogens of normal structure.
The synthesis and degradation of glycogen from D-glucose-l- 
phosphate may now be regarded as:
UDP
>rihoph osp hcofe
^ - 6-/ucose-I-phosphate.
•UTP
A U V PG - p y ro p h o s p h o rL j(a s -e  .
2. dDRG" - gycogen. {ransfejrase. f- br-anchchc^ e n z y m e .
3. Thos phorcjlas^.
/^rr?(jio-Ij (^ixACosiciase, -p o(igo-/^‘4 ^ - gCucanfraos^e^se*
sr
In addition to this main scheme an ancillary pathway of 
degradation has been suggested in recent years by several workers©
A maltase (maltose 4-glucohydrolase) which also shows 
maltotransglucosylase (maltose 4-glucosyltransferase) activity 
has been reported by Giri and c o w o r k e r s . A  series of 
o<-( 1 4 ) -linked oligosaccharides is produced from maltose by 
this enzyme. A similar activity has been observed in rat 
d i a p h r a g m . S t e t t e n  has proposed the following
mechanism:
GiucosijL-G 4- enzLLjme G^McosyL— enz-yme 4- &
GLicos y [-e n zym e  -f- gtjucosyL~G' GljucosyL-gLucosy( 4- -enzyme
(G~ - radioac+CA^e glucose^
An enzyme resembling the plant D-enzyme has been found to 
transfer maltose or maltosaccharides from polysaccharides or 
oligosaccharides to acceptors such as glucose or maltose.
D-enzyme.itself is a transglucosylase which transfers two or more 
D-glucose residues from a donor substrate to an acceptor. The 
donor can be maltotriose or higher maltosaccharides and the acceptor 
D-glucose, maltose or maltosaccharides:
%)- eazix me/ ‘4- / 4- / 4- /
G~ ^ G" ^ G~ -f- G   ^O ’  ^(3 ~ ^ — (3“ -f- (s — > (3 - — ^(3 —  ^G — ^ G~
mcLCto f  rcos e  mojiiop-enirojosG.
Acid maltase has been found in human and rat livers.
No transferase activity was noted in the case of human liver.
The enzyme is also capable of producing D-glucose from
glycogen.^^^^"^^^) It appears to correspond to the enzyme reported
(171 172)
in liver by Rosenfeld.  ^ In its action it resembles the
mould amyloglucosidases, and has been assigned to this 
group by Torres and Olavarria.^^^^^
Another amylase found in liver possesses an 0( -amylase-type 
action. This enzyme has been studied by Torres and Olavarria,^^^^^ 
Rutter and Brosemer (17^^175) G l o c k . M a l t o -
oligosaccharides are produced from glycogen by the -amylase 
action. The action of the maltase, (or amyloglucosidase),produces 
D-glucose from these substrates. Rutter and Brosemer do not
consider that a combination of the K-amylase and maltase activities 
in the liver constitute a major pathway for glycogen degradation.
— glucose.
(177 )
Stetten and Stetten have suggested that the cK-amylase
could produce smaller glycogen molecules, which would then act as 
"seeds" or primers for further glycogen synthesis. They also
discuss the possibility that the transglucosylation reactions, 
which result in no net synthesis or degradation of glycosidic 
bonds, serve to redistribute the bonds, thus causing the variation 
of molecular size and branching characteristics so consistently
(178 179)observed in glycogens. Stetten and Stetten ’ have
demonstrated the constant turnover of glycogen in the liver by 
means of injection of radioactive glucose into the body©
The conversion of hexose monophosphates to a form of energy 
can follow two main pathways —  glycolysis or the pentose phosphate
(180)pathway. It has been demonstrated that carbohydrate
r'l bulose - 5-  P
11'^
x:ylu.lose-5 - P
•7//bos^ -^ -P
degradation in mammals occurs by both p a t h w a y s © G l y c o g e n  
can also be synthesized by reversal of these two pathways,
/ -I Op \
intermediary metabolites such as D-ribose, D-xylose, pyruvate,
lactate and carbon dioxide being incorporated into glycogen.
(riycogen
(3 =  "D - QiucosQ '
g - f r u c fo s e
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/s. phosphoribuiose epimerase ( ri b uios-ephosphore "^ "Gpimerase^  
i-f: frcinskefoIcisc sedohep4cA,(ose — Y" pKosphctfe ' P—gLyceroidehyd-e-
"3 - p h osp h aie. oU-hy drovyace ho n o. fron f^erase^
1Ç. iran^aldolaie {[ g-sedohep-hxlose - 7-pViosphcirte ; glycemJdekyde- 
3 -  pf opp 11 ccle g lyco ( a.ld eh y cdedraj, c '^er ase ^
The four enzymes in these systems most closely related to 
glycogen metabolism are glucose-6-phosphatase (D-glucose-6-phosphate 
phosphohydrolase), phosphoglucomutase (D-glucose-1,6-diphosphate : 
D-glucose-l-phosphate phosphotransferase), phosphoglucoisomerase 
(D-glucose-6-phosphate ketol-isomerase) and hexokinase
(ATP: D-hexose 6-phosphotransferase)*
F.9
Hexokinases occur in all cells where metabolism involves 
free sugars. They catalyse the transfer of one mole of phosphate
from ATP to the sugar, forming a sugar phosphate. They have been
(18'e.
(185)
demonstrated in mammalian b r a i n , l i v e r , a n d  muscle.
Rat liver contains a specific glucokinase and fructokinase.
Recently Vinela has demonstrated a specific glucokinase and
a non-specific hexokinase in rat liver. The glucokinase will 
phosphorylate D-glucose and D-mannose, forming D-glucose- and 
D-mannose-6-phosphates respectively.
Phosphoglucomutase, which catalyses the interconversion of 
D-glucose-l-phosphate and D-glucose-6-phosphate, was first noted
/ "I 00 *1 Qq \
by Colswick and Cori. * It is activated by>fructose-l,
6- d i p h o s p h a t e . L e l o i r  and coworkers showed that 
phosphoglucomutase required a coenzyme which was present in impure 
X»-fructose-1,6-diphosphate and^glucose-l-phosphate. The
coenzyme was found to beaglucose-l,6-diphosphate.
G-- / — P  4- PG-fd ■; ■ G --  -  c U P  -h dephospho - enzyme
4 (^phospho -
en2.yme ^
Gr-(j - cU P  d- dephospko-eazume . G — h - P  f- PG-M
(^phospho- 
enzyme )
The phosphorus occurs as phosphoserine, in the ratio of one
(192 )atom of phosphorus per molecule of enzyme.
Phosphoglucoisomerase catalyses the conversion of
D-glucose-6-phosphate to D-fructose-6-phosphate.
(19b)
Phosphomannoisomerase is a very similar enzyme, giving the
same end product from %-D-mannose-6-phosphate. Both mechanisms 
proceed through cis- or trans-ene-diol intermediates.
Glucose-6-phosphatase is one of the many phosphatases 
occurring in the liver. It has a much higher specificity than 
the acid or alkaline p h o s p h a t a s e s . I t  will catalyse the 
hydrolysis of 0(-D-glucosamine-6-phosphate but has no action
on D-glucose-l-phosphate,Dfructose-6-phosphate or 
^ -glycerophosphate.
A lack of one or more of the enzymes concerned with glycogen 
metabolism leads to the manifestation of glycogen storage diseases. 
The diseases are characterised by abnormally large accumulations of 
normal glycogen, or normal accumulation of glycogens with abnormal 
structures, in various body tissues. A classification of the 
diseases has been made possible, since most of the particular 
enzymic lesions are now known^(^^8,199) Cases have been reported 
where more than one member of a family has suffered from the same 
type of the d i s e a s e , w h i c h  implies that a single 
recessive gene is responsible. Each type of the disease is 
considered to be caused by a distinct recessive gene, although
(11 202)Manners ’ has studied a case of siblings, one of whom
suffered from Type I of the disease, whilst the other suffered 
from Type III.
Type I or von Gierke's disease is the most common type
( 2047and also the first to be reported. The characteristics of
the disease are abnormally high glycogen concentration in the
liver and sometimes the kidney. Normally administration of
glucagon, epinephrine, fructose or galactose causes a rise in the
blood sugar level, but no such increase is observed in Type I
p a t i e n t s . T h e  glycogen has a normal structure,
but the glucose-6-phosphatase activity is practically 
(11 207)negligible. ’ This causes the observed accumulation of
glycogen, and the lack of rise in blood sugar, and has no effect 
upon the glycogen structure.
Type II or Pompe*s disease is the most lethal form, patients 
normally dying before l8 months of age.^^^^^ Glycogen is 
deposited in all tissues, especially heart, muscle and liver.
The structure appears to be n o r m a l . N o  plausible or 
consistent explanation was put forward until Hers measured the 
acid X-(l-^»4)-glucosidase (maltose 4-glucohydrolase) activity 
in the liver, and found it to be strikingly l o w . T h i s  
û^-(l— >4)-glucosidase was found to be associated with the 
l y s o s o m e s , w h i c h  contain powerful hydrolases capable of 
destroying phosphorylase. Thus, in the lysosomal regions, the 
pathway involving < < - ( 1 4)-glucosidase and #-amylase may be 
the only one available for"glycogen degradation, and a low 
(X-d--^4)-glucosidase activity would then result in glycogen 
accumulation. The clinical manifestations of the disease are in
agreement with this interpretation. The deposition of the 
glycogen in distinct granules, which has been noted, suggests a 
very localised enzymic lesion, and the fact that the general
(199)carbohydrate metabolism seems undisturbed could arise from
normal metabolism in the rest of the cytoplasm.
Type III or Cori's disease is characterised by deposition of
glycogen in liver, muscle and heart tissues. The glycogen has a
limit-dextrin structure. Manners and Polglase and
coworkers have studied similar cases. The abnormality was
shown to be due to a deficiency in amylo-1 ,6- g l u c o s i d a s e , t h e
( 20Q )phosphorylase activity being normal. " Phosphorylase can thus
produce a ^-dextrin, which cannot be further degraded, due to the
debranching enzyme deficiency. There is a very low rise in blood
sugar after adrenalin injection, but it is possible to keep patients
(199 )alive by controlling the diet, especially the carbohydrate intake*
Type IV or amylopectinosis has been found in only one patient 
to date.^^^^^ Cori ^^^8,200) examined the liver glycogen, and 
found an extremely low degree of branching and a crystalline form.
The glycogen-iodine complex was a violet colour. These facts 
indicated that the polysaccharide had an amylopectin-like structure.
It was presumed that a branching enzyme deficiency caused the 
abnormality although no experimental evidence was given.
Cirrhosis of the liver occurred in this case, due to the deposition 
of foreign material.
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Only two cases of Type V disease have been reported.
A deposition of glycogen of normal structure occurs in the muscle
fibres. No definite enzymic lesion has been assigned to this
disease as yet. In the second case there is a marked
decrease in phosphoglucomutase activity (5% of normal) and
glycolysis was only 25% of normal.
Type VI(a) disease is caused by liver phosphorylase
deficiency; the liver glycogen structure is normal, but large
amounts accumulate. The muscle glycogen and phosphorylase are
normal. This case provides evidence for the fact that liver and
muscle phosphorylases are two distinct enzymes, and also indicates
that phosphorylase is not of major importance in glycogen synthesis.
The Type VI(b) disease is caused by muscle phosphorylase
deficiency and results in abnormally large deposition of glycogen
in muscle tissues. Cases have been reported by Mommaerts,
Schmid and M c A r d l e . P h o s p h o g l u c o m u t a s e  (D-glucose-1,
6-diphosphate: D-glucose-l-phosphate phosphotransferase),
UDPG-glycogen transferase (UDPG: 0(-1,4-glucan o(-4-
glucosyltransferase), and UDPG-pyrophosphorylase (UTP: X-D-glucose-
1-phosphate uridylyltransferase) were all n o r m a l , e x c e p t  that
(145)in the second case the UDPG-glycogen transferase activity
was only half the normal value. Other reports of low transferase 
(214)
activities in Type I and Type III diseases may point the way
to an alternative synthetic pathway not involving the hexokinase 
and phosphoglucomutase reactions.(^^5)
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The carbohydrate metabolism of the human fetal tissues has
not been studied so extensively as that of the avian and amphibian
embryos. Rat and guinea-pig fetuses are most commonly used in
the mammalian classes.
In the adult liver there is a marked response to hormonal
stimuli. Glucagon and epinephrine stimulate glycogenolysis, thus
causing a rise in the blood sugar level (hyperglycaemia). The
hormones stimulate the production of adenosine-3 5"^ (cyclic)
phosphate, which in turn promotes the conversion of inactive
dephosphophosphorylase to active p h o s p h o r y l a s e . I n  addition
epinephrine has been found to repress UDPG-glycogen transferase
a c t i v i t y , t h u s  effectively blocking the pathway for glycogen
synthesis. Insulin causes hypoglycaemia by stimulating
glycogenesis, thereby removing glucose from the blood. The
( A )
glycogenesis appears to take place in muscle, although de Duve
and his coworkers have supported the view that insulin causes
primarily liver g l y c o g e n e s i s . T h e  adrenal hormone,
adrenocorticotropic hormone (ACTH), exerts an influence on adrenal
phosphorylase analogous to that of glucagon and epinephrine on
( 129 )hepatic phosphorylase.
The stimulus of glycogen synthesis in the fetus by hormones
has been studied fairly extensively, notably by Jost, Jacquot and
he 
(222)
(222 223)coworkers. ’ A sudden onset of glycogen storage in t
fetal liver was noted on the 19th day in the case of the rat.
4(6
and on the 25th day in the case of the rabbit. By means of
hypophysectomies on the fetuses and adrenalectomies on the fetuses
and mothers, the sources of hormonal stimuli were removed.
Glycogen synthesis was found to be stimulated by the adrenal
corticosteroids, which are controlled by the hypophysis.
Maternal adrenal secretions are initially responsible for glycogen
synthesis in the fetus, the role being gradually assumed by the
fetal c o u n t e r p a r t s . A f t e r  the sudden onset of glycogen
synthesis the hypophysis has very little effect, probably because
the adrenals have by then received a large enough stimulus to
(222)proceed without any further control.
Chick embryos store glycogen at a very early stage; for
( 224)example Novikoff and coworkers have demonstrated its presence
after 3 days, together with such substrates as glucose-6-phosphate, 
hexose-diphosphate, phospho-glyceric acid, etc., indicating the 
operation of the phosphorylating glycolysis pathway. Glycolysis
/ ppc \
has been observed in human fetuses aged 8 to 25 weeks.
The tissues are well differentiated biochemically at the beginning 
of this period. The existence of the pentose phosphate pathway 
in tissues of the same fetal ages have also been shown.
(7 8 227 228)Several workers ' * ’ have observed that the placenta
initially assumes the role of the fetal liver, transporting 
carbohydrate material from the maternal to the fetal tissues.
As the fetus begins to accumulate hepatic glycogen this placental
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function gradually ceases. Villee quotes 12 weeks as the
duration of the placental function in human fetuses.
Demonstration of glycogen in human fetal tissues at fairly 
early stages depends exclusively upon histochemical techniques.
In general it has been found to occur more abundantly in tissues
/ppQ p? 2\
other than hepatic ones up to 7 or 8 weeks. In most
cases it appears to be concentrated in the epithelial layers of
various parts of the embryo. Mackay and his coworkers 232)
consider that it takes part in the promotion of rapid growth in
these areas. Shapovalov has found traces of glycogen in the liver
cells of 6, 7 and 8 week f e t u s e s . M a c k a y  and his
coworkers have found more evidence in support of the fact that the
yolk sac (placenta) functions in place of the liver in the early
embryonic stages. Its epithelial cells contain glycogen and it
is connected to the liver by a vascular system. In the horizons
XIII and XIV (23-30 days) they noted the beginnings of the
shift of function from yolk sac to liver, when 3-Ducleotidase and
non-specific esterase activities became evident in liver cells
(234)for the first time. Kitamura reports that glycogen is first
apparent in the human fetal liver at 4 months, and that it rises 
to a maximum in the 6th to 9th months. It disappears abruptly 
at term, but with premature births there is no such decrease.
In contrast Delong and coworkers could demonstrate no hepatic
glycogen in human fetuses until just before term, although it was 
present in lung tissue throughout fetal life, until the onset of
4 7
hepatic glycogen storage.
The sudden accumulation of glycogen in the fetus previously 
(97 98)mentioned ’ has been observed in most mammals just prior to 
term. Dumm,^^^^^ D a w k i n s , a n d  Weber and Cantero have
(97)studied rat fetuses; Nemeth,Insull and Flexner, Hard, Reynolds
and Winbury and Ducommun-Lehmann have studied guinea-
(240) (99)pigs and Shelley and Dawkins sheep. In all cases these
workers have noted that the rapid increase in glycogen content is
followed by a sharp decrease a few hours after birth. The process
of building up the glycogen reserves to the adult level may take
several days. With two-day premature births the same pattern was
found.(99)
Nemeth has attributed this sudden decrease in glycogen
content to the appearance of glucose-6-phosphatase activity a few
days before birth. This activity increases greatly immediately 
(99 )after birth, thus causing the depletion of glycogen.
The human fetus appears to possess low glucose-6-phosphatase
ts
(227)
activity at 11 weeks on the other hand. Villee repor
that by 22 weeks it has reached half the normal adult level.
(242)The work of Auricchio and Rigillo points to a low and fairly
constant activity in 5-9 month fetuses. They could show no sudden 
increase in enzyme activity corresponding to the normal mammalian 
pattern.
The mammalian fetus has been shown to possess many of the
n(97)enzymes involved in glycogen synthesis. Nemeth and Burch
and coworkers have found fairly high phosphorylase activity
in the guinea-pig and rat fetuses in the last few days of gestation,
(244)
while Kornfeld and Brown observed an increase to 3 times the
normal level of the adult guinea-pig in the period between the 
65th day of gestation and the second postnatal day. By the 6th 
postnatal day it had fallen to the normal adult level.
(97)Phosphoglucomutase activity is high in fetal guinea-pig 
(237)
and rat livers, as is phosphohexoisomerase in the fetal and
newborn rat liver.
Hexokinase activity increases in the fetal guinea-pig liver,
until on the 50th day it is as high as the normal adult level.
During this time the placental activity decreases correspondingly.
The activity in the fetal rat liver decreases markedly from the 5th
day prior to term onwards, accompanied by a decrease in
phosphofructokinase activity. This is indicative of a fall in the
high rate of glycolysis found in the f e t u s . C o u p l e d  with
the high phosphorylase activity and the appearance of glucose-6-
phosphatase prior to term, it appears to favour glycogen conversion
(243)
to glucose rather than lactate.
UDPG-glycogen transferase (UDPG: %-1,4-glucan X-4-
glucosyltransferase) and UDPG pyrophosphorylase (UTP: %-D-glucose-
1-phosphate uridylyltransferase) activities have been measured in
(244)
the fetal guinea-pig and were found to increase from 45 days
to term, when they reach the adult level.
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Glucose-6-phosphate dehydrogenase (D-glucose-6-phosphate; 
NADP* oxidoreductase) and 6-phosphogluconate dehydrogenase 
(6-phospho-D-gluconate: NAD^ oxidoreductase) activities reach the 
adult level by term, but then decrease for 3 weeks.
Burch and coworkers have attributed this to the fact that the 
enzymes increase in activity in the presence of a high 
carbohydrate concentration. However, during the 3 week nursing 
period, the only food given is milk, which has a high fat rather 
than carbohydrate content.
*NADP = nicotinamide adenine dinucleotide phosphate.
^NAD = nicotinamide adenine dinucleotide.
EXPERIMENTAL
f/
Solvents used for chromatography
I. ethyl acetate: acetic acid: water 9* 2: 2 bij vTDlume.
(249)
II. ethyl acetate: pyridine: water 10: 4: 3
III. n-butanol: ethanol: water 40:11:19
IV. n-butanol: pyridine: water 6: 4: 3
V. acetone: water 1: 1
Sprays used for locating compounds
lo p-anisidine-hydrochloride, 2%(w/v ) in n-butanol.
II. 0*93g« aniline and l*66g. phthalic acid in 100ml. n-butanol.
III. silver nitrate solution in acetone, followed by ethanolic 
sodium hydroxide.
IV. Ninhydrin, 0*4% in n-butanol (95%)*^^^^^
Samples used
Ao Urine samples taken from patient G.B. when fed on a diet 
containing amylopectin.
B. The above sample de-ionised with Biodeminrolit (carbonate form).
C. Sample of lactose-reduced milk.
Do Urine samples taken from G.B. when fed on a diet containing 
amylose and lactose-reduced milk.
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Experiment 1.
Extraction of glycogen with alkali 
Liver tissue was stored at -15* until required for extraction 
of glycogen. Liver tissue in the frozen state was ground into 
small pieces and added to a 30%(w/v ) solution of potassium 
hydroxide in water (Ig. of tissue to 9ml. of potassium hydroxide 
solution). The mixture was heated at 100 for 2-3 hr. or until 
well-digested. After removal of any solid material the solution 
was cooled and glycogen precipitated with ethanol. Nitrogenous 
material and phosphate were removed from the glycogen by the 
procedure of Somogyi.
Experiment 2.
Extraction of glycogen with trichloracetic acid 
Liver tissue was homogenised with ice-cold 10% (w/v ) 
trichloracetic acid for 5 min. After centrifuging at 0° the 
supernatant liquid was kept, and the remaining tissue re-extracted 
four more times with trichloracetic acid. The glycogen was 
precipitated from the pooled supernatants by 5 volumes of ethanol. 
After standing overnight at the glycogen was centrifuged, 
washed three times with ethanol and once with ether and dried 
under reduced pressure in the presence of phosphorus pentoxide. 
Experiment 3
Determination of purity of glycogen 
Glycogen (ca. 5mg.) was hydrolysed with 2N-sulphuric acid
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(ca. 2ml.) for 2 hr. at 100*. After cooling, the solution was
neutralised with N-sodium hydroxide and the volume made up to
25 ml. with distilled water. 4 ml. aliquots were assayed for
(257)glucose content by the method of Somogyi. The purity of the
glycogen was expressed as a percentage of glucose found in a known
weight of glycogen. The results obtained on fetal and other
glycogens are given in Tables I -and ^ VI,
Experiment 4.
Determination of ^-amylase activity
The activity of sweet-potato ^-amylase was measured using
( ? ^
the method of Hobson, Whelan and Peat, except that the
temperature of incubation was 50*. The activity was defined as
the number of mg. maltose liberated by 1 mg. enzyme under the
above conditions.
Experiment 5#
Incubations of glycogen with ^-amylase
Glycogen (30 mg.), ^-amylase (l800 units), and 0*2M-sodium
acetate buffer pH 4*6 (5ml.), in a total volume of 25ml., were
incubated at 30* for 24 hr. The maltose liberated was determined
( 2S 7  )
by the method of Somogyi. A portion of the digest was
examined by descending chromatography on Whatman No.l. paper in 
solvent I, and the sugars located with spray I.
Experiment 6.
Glycogen (ca. Img.), ^-amylase (50-70 units) and 0*2M-sodium 
acetate buffer pH 4*6 (0*4ml.), in a total volume of 10ml., were
5f
incubated at 30* for 24 hr. 4ml. of the digest was removed and
diluted to 30ml. with water* Aliquots of 2ml. were assayed for
(259)maltose content by the method of Parke and Johnson. The
absorptions were measured on a Hilger "Spekker" at 7 1 0 using 
an Ilford No. 609 filter. The proportions of the constituents 
of individual digests and the amount of dilution required varied 
with the amount available of each glycogen sample.
Experiment 7#
Preparation of ^-amylase
%-amylase was prepared from human saliva by the method of
It
(261)
Fischer and S t e i n . T h e  crystallisation procedure was omi ted
and the enzyme freeze-dried in 0*2M-sodium citrate buffer pH 7*0
{86 )
The activity was measured by the method of Manners and Wright, 
one unit of oC-amylase activity being defined as the quantity of 
enzyme which liberates Img. of apparent maltose (measured in this 
case by the Somogyi reagent) from 1ml. of 1% starch in 3min. at 35 
Experiment 8.
Incubation of maltose with ^-amylase 
^-amylase preparation (Img.), maltose (3mg.), and 0*3% 
sodium chloride (iml.), in a total volume of 10ml., were incubated 
at 33^ • Samples were taken at hourly intervals from 1 to 12 hr., 
then at 24 and 30 hr. and examined by descending chromatography on 
Whatman No.l. paper in solvent I. Sugars were located with 
spray I.
55
Experiment 9.
Incubation of glycogens with %-amylase
Glycogens of known chain length were incubated with -amylase
to check that the particular preparation conformed with the
equation derived by Manners for the calculation of CL.
Digests contained glycogen (12*5 mg.), ^-amylase (50 units) and
0»5% sodium chloride in a total volume of 25ml. and were incubated
at 35* for 15 hr. The apparent percentage conversion to maltose
(257)was measured by the method of Somogyi. A portion of the
digest was evaporated under reduced pressure to a small volume and 
examined by descending chromatography in solvent I using Whatman 
No.l. paper. The sugars were located with spray I.
Experiment 10.
Glycogens of known and unknown CL (0*5 - 1*5 mg.), 0*5%
sodium chloride (0.2ml.) and ^-amylase (2-6 units), in a total
volume of 10ml., were incubated at 35° for 15 hr. After
appropriate dilution, the maltose content was measured by the
(259)method of Parke and Johnson. Chromatographic investigation
of the digests was as described in Experiment 9»
Experiment 11.
Periodate oxidation of glycogens 
Glycogen was oxidised with potassium metaperiodate at room 
temperature by the method of Bell and Manners and by sodium
metaperiodate by the modification of the method of Potter and
5^
Hassid.^^^^ In most cases the quantity of glycogen used was in
the region of 50mg# and the digests were reduced in scale
accordingly.
Experiment 12.
Incubation of glycogen with glucamylase
Rabbit liver glycogen (29*7mg.), glucamylase solution* (5ml.)
and M-sodium acetate buffer pH 4*05 (2ml.), in a total volume of
25ml., were incubated at 50*. Aliquots of 2ml. were withdrawn
at time intervals of 2, 4, 10, 19‘i'i 21 and 26 hr. and the glucose
(257)formation measured by the method of Somogyi.
Experiment 15.
Combined reaction of ^-amylase and 
glucamylase on glycogen
Rabbit liver glycogen (ll6«2mg.), 0*2M-sodium acetate buffer
pH 4*6 (20ml.), and ^-amylase (ca. 7000 units) in a total volume
of 100ml. were incubated at 50 . Aliquots of 2ml. were removed
after 24, 44 and 48 hr. intervals. The maltose formed was measured
by the Somogyi r e a g e n t . A  portion (25ml.) of the digest was
incubated at 50* with 5ml. glucamylase solution. Aliquots of 2ml.
were withdrawn after 47, 116 and 119 hr. and the glucose formed
( P ^
measured by the Somogyi reagent. A portion of this digest
was evaporated under reduced pressure to a small volume and examined 
by descending chromatography on Whatman No.l. paper in solvent I.
The sugars were located with spray I.
* preparation by Dr. J.G.Fleetwood
Experiment 14.
Isolation of limit-dextrins
Baboon liver glycogen (I30*2mg.), 0*2M-sodiiim acetate buffer
(20ml.) and ^-amylase (?800 units), in a total volume of 100ml.,
were incubated at 30  ^ for 48 hr. to allow for completion of enzyme
action. Aliquots of 2ml. were removed and the maltose formed
(257)measured by the method of Somogyi. The remaining solution
was dialysed overnight against running tap water and reduced in 
volume by evaporation under reduced pressure. Protein was removed 
from the solution by shaking for 1 hr. with a mixture of 0*23 
volumes of chloroform and 0*1 volumes of amyl alcohol.
The aqueous layer was dialysed again and evaporated to a small 
volume as before. The limit dextrin was precipitated with ethanol, 
washed 3 times with ethanol and once with ether and dried under 
reduced pressure in the presence of phosphorus pentoxide. The 
purity of the dextrin was determined by the procedure described 
in Experiment 3*
Experiment 13*
Baboon glycogen (121*3mg.), N-sodium acetate buffer pH 4*03 
(8ml.) and freeze-dried glucamylase preparation* (60mg.), in a 
total volume of 100ml., were incubated at 30° for 48 hr. Aliquots 
of 3#1* were withdrawn and the glucose formed measured by the 
method of Somogyi.^^^^^ The isolation of the limit dextrin 
followed the procedure described in Experiment l4.
* preparation by Dr. J.G.Fleetwood
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Experiment 16.
Periodate oxidation of dextrine 
Glycogen /3-dextrin (30mg.) was oxidised with 8% (w/v ) 
sodium metaperiodate (iml.) in a total volume of 10ml. under the 
conditions of Manners and Archibald.
Experiment 17»
Glycogen glucamylase limit-dextrin (29"2mg.) was treated
as described in Experiment l6.
Experiment l8.
Incubation of dextrine with -amylase
Glycogen ^-dextrin (l*lmg.), tx-amylase (4 units) and 0*5%
sodium chloride (0*2ml.), in a total volume of 10ml., were
incubated at 35* for 13 hr. After dilution aliquots of 2ml. were
(259)assayed for maltose by the method of Parke and Johnson.
Experiment 19.
Glycogen glucamylase limit-dextrin (0*9mg.) was incorporated 
into a digest and the maltose liberated determined as in 
Experiment l8.
Experiment 20.
Incubation of rabbit liver glycogen with "Diazyme". 
’’Diazyme'* (Img.), glycogen (29*6mg.) and M-sodium acetate 
buffer pH 4.03 (2ml.), in a total volume of 23ml., were incubated 
at 30*. After 24 hr. the glucose production was measured by the 
Somogyi reagent.
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Experiment 21.
Separation of enzymic activities of "Diazyme"
A saturated solution of **Diazyme” in 1ml. of water was 
applied in a streak to Whatman No.3* paper. Descending 
chromatography in solvent V was carried out for 7 hr. After 
drying in cold air, the amylolytic activities were located by 
cutting strips 3cm. wide from each side of the paper and incubating 
1cm. portions of these with 0*05% amylose solution (1ml.) and 
0.02M-sodium phosphate (pH6*l8)-0*03M-sodium chloride buffer (3ml.) 
for 6 hr. at 35 • Aliquots of 3ml. were added to N-sulphuric 
acid (Irai.) and 0*006% iodine solution (1ml.). The amylolytic 
bands were characterised by a marked decrease in the blue colour 
of the iodine-amylose complex.
Experiment 22.
The portions of the paper showing amylolytic activity were
eluted with the phosphate-chloride buffer. The eluant (3ml.),
glycogen (30rag.) and M-sodium acetate buffer pH 4.03 (2ml.), in
a total volume of 23ml., were incubated at 30* for 24 hr. and the
( PR*7 ^
glucose production measured by the Somogyi reagent.
Experiment 23.
Measurement of the absorption spectra 
of glycogen-iodine complexes
Glycogen (2*3mg) in 2*3 ml. water and 2*3 ml. iodine solution
(0*2% iodine and 2% potassium iodide in water) were made up to 23 ml.
with water, adding one drop of 6N-hydrochloric acid. The absorption
6o
of the glycogen-iodine complex was recorded in the spectral region 
400 - 700 on the Unicam 8.P.3OO, using 1cm. cells. The 
reference solution was a 0*02% iodine, 0*2% potassium iodide 
solution.
Experiment 24.
Extraction of concanavalin A 
Concanavalin A was extracted from jack-bean meal with a 
0*9% sodium chloride solution as described by Cifonelli and 
S m i t h . N o  polyvinyl alcohol was added to the extract, but
all subsequent determinations were carried out on the same day,
under identical conditions*
Experiment 23»
Measurement of glycogen values
Glycogen values were measured according to the method
described by Smith and c o w o r k e r s . T h e  turbidity was measured 
at 430 myA. on a Hilger "Spekker", using an Ilford No. 6OI filter.
The standard glycogen used was a sample of calf liver glycogen.
Some results are given in Table VII.
Experiment 26.
Partial acid hydrolysis 
Trace precipitates of glycogen obtained from human fetal livers 
of ages 11-J-, 12, 13-13^ and 14J-13 weeks were subjected to partial 
acid hydrolysis with 0*03N-sulphuric acid for 8 hr. according to 
the conditions of Wolfrom, Lassetre and O ' N e i l l . T h e  
hydrolysates were examined by descending chromatography in solvent I
é/
on Whatman No.l. paper and the sugars located with spray I.
Samples of baboon liver glycogen and fetal liver glycogen (26 weeks) 
were treated in the same manner. The hydrolysates of the latter 
two were reduced with potassium borohydride and the borohydride 
removed by several treatments with methanol. The hydrolysates 
were then examined by electrophoresis on Whatman No.3. paper in 
0*062M-sodium molybdate buffer for 43 min. at 21 v/crn.
The sugars were located with spray III.
Experiment 27»
Measurement of glucose-6-phosphatase activity 
Glucose-6-phosphatase activity in liver was determined by the 
method of Calderbank, Kent and coworkers,  ^ using dipotassium 
glucose-6-phosphate as substrate in 0«lM-potassium citrate buffer 
pH 6*3• The inorganic phosphate liberated after 10, 20 and 30 
minutes* incubation at 35*^  was determined by the method of Fiske 
and S u b b a r o w . R e s u l t s  were expressed as Moles of phosphate 
liberated per hr. per g. frozen tissue.
Experiment 28.
Measurement of phosphoglucomutase activity 
Phosphoglucomutase activity was measured by the method of 
Najjar using 0.02M-dipotassium glucose-l-phosphate as a
substrate and 0*03 M-cysteine pH 7*3 with 6mM-magnesium sulphate 
as the buffer. Incubations were carried out at 35* for 3> 10 and 
13 min. The inorganic phosphate was liberated by hydrolysis with
sulphuric acid and measured as in Experiment 27. Activities were 
expressed as yx. Moles of hydrolysable phosphate used per hr. per g. 
frozen tissue (see TableIV).
Experiment 29.
Measurement of phosphoglucoisomerase activity 
Phosphoglucoisomerase activity was determined by a slight 
modification of the method of Glock and -McLoan. The reaction
mixture contained 1 yx mole dipotassium glucose-6-phosphate in 0*4ml
0.06M-Tris pH 9*0 and 0.1ml. liver homogenate. The fructose-6- 
phosphate formed was measured colorimetrically by the ethanolic 
resorcinol reagent of Roe. Results were expressed in units
of activity per mg. frozen tissue, one unit being defined as the 
quantity of enzyme that produces 1 Mole of fructose-6-phosphate 
per min. at 37* . (See Table V ).
Experiment 30>
Examination of sugars in sample A 
The samples were examined by descending chromatography in 
solvents I, II, III and IV on Whatman No.l. paper. Sugars were
located with sprays I, II and IV.
Experiment 31.
Samples A and B were examined by electrophoresis on Whatman 
No.3. paper in 0*lM-sodium borate buffer pH 10*0, at 30 V/cm,
for 1 hr. Sugars were located with spray III.
(^5
Experiment 32.
The reducing sugars in sample B were reduced to the corresponding 
alcohols with potassium borohydride. They were examined by 
electrophoresis on Whatman No.3- paper in 0*062M-sodium molybdate 
buffer pH 5*0 at 21 V/cm. for 45 min. Sugars were located with 
spray III.
Experiment 33»
Sample B was heated at 100* for 3 hr. with Amberlite IR-120
(H+ form) ion exchange resin in order to hydrolyse the sugars.
The resin was filtered off, washed with water, and the combined 
«
washings and filtrate evaporated under reduced pressure until 
almost dry. The solution was examined by descending chromatography 
on Whatman No.l. paper in solvent II and the sugars located with 
spray I.
Experiment 34.
A portion of sample A was placed in a streak on Whatman No.3* 
paper and chromatographed in solvent II. The position of the 
isomaltose band was located by spraying strips cut from each side 
of the paper with spray I. The band was cut out and the sugar 
eluted with water. The resulting solution was hydrolysed with 
resin as described in Experiment 35 and the hydrolysate examined 
by descending chromatography on Whatman No.l. paper in solvent II, 
and the sugars located with spray I.
Experiment 33*
Chromatographic investigation of sample C 
Sample C was placed in a streak on Whatman No.3* paper.
After chromatography in solvent II the sugars were located in strips 
from each side of the paper with spray I. The two bands behind 
lactose were cut out and eluted with water. The eluants were 
hydrolysed with resin as described in Experiment 33 and evaporated 
almost to dryness under reduced pressure. They were examined by 
descending chromatography on Whatman No.l. paper in solvents I and 
II, and the sugars located with spray I. Another chromatogram 
in solvent II was sprayed with reagent IV in order to locate the 
sugars.
Experiment 36.
Chromatographic investigation of sample D 
Sample D was treated as described in Experiment 33*
Experiment 37*
Electrophoretic examination of sample D 
A portion of sample D was treated with potassium borohydride 
in order to convert the reducing sugars to the corresponding 
alcohols. Electrophoresis on Whatman No.3* paper was carried out 
in 0*062M-sodium molybdate buffer pH 5*0 at 21 v/cm. for 43 min. 
Sugars were located with spray III.
Experiment 38.
Studies on liver specimens from cases 
of suspected glycogen storage diseases
Four liver samples, P.M., D.H., J.H. and S.L., were ground 
with trichloracetic acid and the glycogen precipitated with ethanol 
as described in Experiment 2. Average chain lengths of the 
glycogens were determined by incubation with (X -amylase 
(Experiment 10) and exterior chain lengths were determined by 
incubation with |3-amylase (Experiments 5 and 6). The values of 
% of the glycogen-iodine complex was determined as in 
Experiment 23*
,a3'. : .
MAIN SECTION
<5/
(a) Studies on glycogens
The readily available supplies of laboratory-bred animals 
has facilitated research into their fetal metabolism and 
development. Human tissues, however, can only be obtained from 
miscarriages or medically terminated pregnancies, and a comprehensive 
survey of the whole gestation period from any aspect is thus made 
very difficult. In this study the fetal livers obtained ranged 
in age from 11-g to 26 weeks. The work was undertaken (i) to 
provide information on the storage and structure of glycogen in 
the human fetal liver and (ii) to examine some of the enzymes 
concerned with glycogen metabolism. In addition to increasing the 
fundamental knowledge of the developing human liver, such information 
would have a direct bearing on the glycogen storage diseases in 
children.
The stability of glycogen to hot concentrated alkali has been
(270 271 272)questioned by several workers.  ^ * Reductions in the
molecular weights of glycogens by alkali treatment are not
(270 275) (274)consistently observed, however, ’ and Stetten and Katzen
have suggested that, provided anaerobic conditions are maintained,
only the reducing end of the molecule will be affected. The
products are polysaccharide acids and a small amount of free
isosaccharinic acid.
&g
C H ; OH
H O O C  C    CH^.CHOH, CHjOH
OH
Degradation does occur if hot dilute alkali is used as the 
(270 275)
extractive, ’ as oxygen is more soluble in the dilute
solution and anaerobic conditions no longer prevail.
Trichloracetic acid is generally considered to be less
(277 )effective as an extractive unless adequate homogenisation
(278) o (P7Q)
is used or the homogenate heated to 100 for I5 minutes.
In the extraction of the fetal glycogens (Table I) trichloracetic
acid was used, as previous extractions of human and other
mammalian liver glycogens had resulted in higher yields by this
method than by the use of alkali. The samples were also purer,
and contained only trace amounts of nitrogen. In the case of
many fetal glycogens it was important that fairly pure samples
should be obtained initially, since further purification of the
1-3 mg. samples obtained would have resulted in the loss of the
sample.
Fetal livers aged ll-J-j 12, 13-13i^ and 14^-13 weeks gave only 
a trace of precipitate when extracted with trichloracetic acid. 
Partial acid hydrolysis of these precipitates (Experiment I6), 
followed by chromatographic examination, showed that no reducing 
sugars were present, whereas the two control hydrolysates (glycogen
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from a 26 week fetal human Liver and baboon liver glycogen) were 
shown by chromatography and electrophoresis to contain glucose, 
maltose and isomaltose, proving the presence of (X^ -(1— >4)- and 
^xf-(l—>6)- linkages in the original molecule. Milligram quantities 
of glycogen have been obtained from fetal livers ranging from 13 to 
26 weeks of age (Table I). Kitamura found that deposition
of glycogen in the human fetal liver began at 1? weeks, 3? weeks 
later than in this study, although the substantial increase in 
storage of liver glycogen beginning at 26 weeks (Fig.I) corresponds 
very closely to his observations. The increase in glycogen storage 
is not steady, but can, be accounted for by normal biological variation, 
Small quantities of glycogen have also been found in the human 
liver as early as 6 weeks by Shapovalov who used
histochemical techniques to identify the polysaccharide. In support 
of this, Mackay and his coworkers have suggested that the 4 week-old 
fetal liver is almost ready to assume the function of glycogen 
s t o r a g e . T h e  chemical methods that have been employed in the 
present study do not appear to have been sensitive enough to reveal 
such small quantities of glycogen; not until the 13th week of 
gestation is glycogen detectable by chemical means. The report 
by belong and coworkers that they could find no glycogen in
the fetal liver until a few weeks before term is difficult to 
reconcile with other observations. The evidence for the presence 
of glycogen outweighs this single latter report. Most of the
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research carried out on the detection of glycogen in fetal tissues
has employed histochemical techniques and the variation in results
(234) (229)can be seen by comparing those of Kitamura and Shapovalov,
where there is a discrepancy of 11 weeks between the dates given
for the first appearance of glycogen in the liver. It is probable
that the stains, apparatus and individual techniques employed will
all influence the results.
Table I
Glycogens obtained from fetal livers*
Age Sample
number
Fresh wt. 
of sample
% purity 
of
glycogen
Wt. of
pure
glycogen
% glycogen 
in liver 
tissue
13i wk. 895,935 420 mg. 51 1-63 mg. 0.39
13i-l6 !f 1074,1164,
1172
846 » 45.2 1-93 II 0.23
16-^17 II 1058,1148,
1183
929 " 58 2-26 II 0*24
l8-^ 11 1152,1128,
1133
554 " 58 2-33 II 0'46
20 II 1117,1190,
1184
870 " 22 2-37 I t 0.30
2li II 893,894 465 " 27*2 2-23 II 0"48
2li II 1167,1048,
1168
1567 " 68 3-13 II 0-20
23i II 1182,1084 1944 " 60 4-68 II 0*24
23 II 850 246 " 83.5 1-73 I t 0.71
26 I t 926 180 " 66.3 3-03 II 1-70
26 II - 28.83 g. 86.6 320 II 0.96
* Most glycogens were obtained from pooled fetal tissues
7Z
In all mammalian species studied so far, there is a marked
increase in glycogen deposition at a fairly late stage of gestation.
(2P3 P3Q p41)From the figures quoted ' ' it appears that in rats and
guinea-pigs the onset of glycogen deposition occurs after about 
85% of the total gestation period has elapsed. On this basis no 
marked increase in glycogen storage should be noted in the human 
fetus until approximately the 33rd week of gestation. However, 
from observations made on lambs, m o n k e y s , r a b b i t s  and
pigs,^^^^^ it would appear that the stage at which glycogen 
accumulation increases rapidly is related to the class of mammal.
In rats, guinea-pigs and rabbits (rodents) it occurs fairly late 
in gestation, after 90%,^^^^^ 80%^^^^^ and respectively,
of the gestation period has elapsed. In man (primate) it occurs 
after 66% of the gestation period has.elapsed, while in Rhesus 
monkeys glycogen stores are very high at 113 days (67% of 
gestation). Unfortunately no fetuses younger than 113 days 
were studied, so it is not known exactly when glycogen storage 
begins its increase. Pigs and sheep (ungulates) vary rather 
widely, the increase occurring after 88% of gestation in the 
former and 6l% in the latter.
The factors responsible for the storage of glycogen in the
(222 223)liver are largely hormonal. Adrenal and pituitary hormones ’
(218 221)and insulin are known to stimulate glycogen synthesis
and it is interesting to note that in fetal lambs the appearance 
of the islets of Langerhans (the source of insulin) coincides with
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the accumulation of glycogen in the fetal liver. Thus it
would seem that the fetal hormonal systems of the primates and,• 
to a lesser degree, of the ungulates, mature at a far earlier 
stage of gestation than those of the rodents*
The deposition of glycogen in tissues other than hepatic has
(229 250 255)been observed at very early stages of gestation. * '
It is generally accepted that there is no hormonal control over 
these glycogen stores, and their formation is initiated most 
probably when the enzyme system for glycogen synthesis and 
breakdown is completed in the particular organs. Glycogen supplies 
in these areas normally decrease as gestation advances and are very 
low at term.
The late appearance of the enzyme glucose-6-phosphatase and
subsequent depletion of glycogen stores has been noted in several
mammalian fetuses. The function of this enzyme is presumably to
provide an abundant supply of blood glucose, in order that the
fetus will have sufficient energy to survive birth and the first
few days of neonatal life. There have been no reports of the
same pattern in human fetuses, although indirect evidence obtained 
(254)by Kitamura indicated that hepatic glycogen decreased
rapidly at birth. It is also known that the level of blood 
glucose is high in new-born infants. ’ Glucose-6-phosphatase
activities determined on 8 fetuses ranging in age from 13 to 23 
weeks (Experiment 2?) showed that either the enzyme was completely 
absent, or that its activity was so low as to require a more
sensitive method for its determination. It was very unlikely
that the enzyme had been inactivated by leaving the liver specimen
o
too long either at room temperature or at -15 , since portions of 
mouse liver were found to possess fairly constant activity when
o
left at room temperature for up to 3 hr. and at -15 for up to
6 months. Very low activities have been reported by Cori and
Schulman for an l8 week-old human fetus, and by Auricchio
(242)and Rigillo. The latter workers examined human fetuses in
the 5-9 month range and could not detect any sudden increase in
activity. If this does occur, it is presumably very close to or
(227)just after term. The report by Villee of a fully active
enzyme at 20 to 24 weeks of gestation was based on the production 
of glucose by slices of fetal liver. This method does not exclude 
the possibility that the glucose arises from the ^-amylase and 
oC-glucosidase pathways from the liver glycogen. This could well 
explain the high activities which are not in agreement with those 
determined by the release of inorganic phosphate from glucose-6- 
phosphate. Villee himself suggests that, taking into account the 
variation in the activities recorded, the appearance of the enzyme 
may sometimes be delayed until birth or after.
Human fetal liver is of great value to the medical world as 
it possesses the capacity of producing red blood cells 
(erythropoiesis)• Owing to this, the demand for the liver tissue 
is high and many of the samples obtained for extraction of glycogen
/r
were of the order of 1-5 mg. glycogen (Table I). To determine 
the structure of these glycogens, the micro-methods employing the 
enzymes -amylase and c<-amylase (Experiments 6 and 10) were 
adopted. When tested on glycogens of known structure, each 
method gave results in good agreement with those determined by 
periodate oxidation (Experiment 11) and ^  -amylolysis using the 
Somogyi reagent to measure the maltose produced (Experiment 5)
The cxl-amylase preparation (Experiment 7) was found to have only a 
slow hydrolytic action on maltose (Experiment 8). Glucose 
production after 12 hr. was barely discernible, while after 24 hr. 
it was far more marked. The incubation time of 15 hr. was 
therefore chosen as being convenient and liable to produce no more 
than trace amounts of glucose from the action of the maltase.
The structure of the fetal glycogens (Table II) obtained by 
these methods show them to be within the range of variation 
encountered by previous workers (Table III). The average chain 
lengths vary from 12*5 to 14*5 D-glucose units and the average 
exterior chain lengths from 7*7 to 10*2 D-glucose units. The 
structures of the glycogens from the l8^ week-old and 21^ week-old 
(1167, 1048, 1168) fetuses indicate that the outer chains are a 
little shorter (1-2 D-glucose units) than normal. It is doubtful 
whether this finding has any significance, as the methods employed 
have an error of - one D-glucose unit. (86)
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TABLE II
Structures of fetal glycogens
Age Sample
number
CL by 
o<-amylase
ECL by 
^-amylase
.% ICL ^
13-J wk. 895,935 14*1 9*2 3*9
15i-l6 " 1074,1164,
1172
13*0 10-2 1*8
16^-17 " 1058,1148
1183
13*5 8*7 3*8
l8i " 1152,1128,
1133
12-3 7*7 3*8
20 " 1117,1190,
1184
14-5 - -
2li " 893,894 13*7 9*1 3.6
2li " 1167,1048,
1168
13-6 8*0 4.6
23i " 1182,1084 14'1 9*0 4.0
25 " 850 l4*0 8*7 4.3
26 " 926 13*3 8.4 4:'i
26 " - 13-9* 8.9 4.0
+ ICL = CL - ECL - 1
* CL by periodate oxidation = 13*4
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TABLE III
Structures of other human and
mammalian glycogens
Sample CL ECL ICL
♦Human liver 14.0 8-9 5-6
Human muscle 11 7 3
Rabbit liver IV 13 8-9 3-4
Rabbit liver V 14 9-10 3-4
Rabbit muscle II 11 6-7 3-4
Cat liver IV 13 9-10 2-3
Fetal pig liver 11 8 2
Fetal sheep liver 13 9 3
Horse liver 11 -
Ox liver 12-13 - -
t values taken from reference 25.
* from a case of glycogen storage disease.
Glycogen from the 23^ and 26 week-old fetuses gave glycogen values 
with concanavalin A of 0*82 and 0*89,respectively,(Experiment 25), 
which, although the lowest values in this study^were within the
(42)range of variation 0*76 to 1*36 found by Manners and Wright. 
Glycogen from the 26 week-old fetus formed a reddish-brown complex 
with iodine, the absorption maximum being at 470 ny^(Figure II). 
Both these latter results support the finding that fetal glycogen
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structure is very similar to that of normal mammalian glycogen. 
Since no striking differences between the structures of 
fetal and adult glycogens were encountered in any of the liver 
tissues investigated, this can be taken as an indication that the 
balance of the enzymes responsible for glycogen synthesis and 
degradation is very similar in fetal and adult liver tissues.
If it is true that glucose-6-phosphatase activity does not develop 
until term, this would have no effect on the structure of the fetal 
glycogen, but merely upon the amount that is stored*
The presence of phosphoglucomutase was observed in all fetal 
livers studied (Experiment 28).
TABLE IV
Phosphoglucomutase activity in 
fetal livers
Age of 
sample
Sample
number
Activities 
(ywMhydrolysable P 
used/hr./g.frozen tissue)
9 wk. llBO 3108
21 »• 1173 1437
23 " 1125 2679
24 " 1018 2326
Quantitative information on the normal level of activity of this 
enzyme in the human liver is rare, due to the scarcity of suitable 
biopsy material. The most comprehensive study is by Weber and
Cantero, who give a value of 10149 ± 5046 ^ A(/hr./g. wet 
wt. for human liver* Calderbank and coworkers give values
of 5088, 1556, and 1704yt^Ai/hr*/g. frozen tissue, when the original 
liver homogenate is diluted 10-, 100- and 500-fold. The values 
in Table IV correspond more closely to Calderbank*s results, 
although such high dilutions were not employed. Taking the results 
of Weber and Gantero as being more representative of normal values 
at lower dilutions, the fetal liver enzyme is rather low in activity. 
Nevertheless, its presence cannot be denied. Weber and Gantero 
also give figures for the activity of phosphoglucoisomerase in the 
human liver. Their value of I563O + 5241 ycM fructose-6-phosphate/ 
hr./g. wet wt., i.e. approximately 250 units/g. wet wt. is five 
times higher than those found in the present study (Experiment 29).
TABLE V
Phosphoglucoisomerase activity in fetal livers
Age Sample
number
Activity * 
(units/g. frozen tissue)
13 wk. 1162 56
14^ ” 1009 32
16 »' 1172 31
17 ” 940 61
22 ** 1168 48
! unit = the quantity of enzyme which produces 1 ycAt
fructose-6-phosphate per minute at 37 •
8!
Table V shows that the enzyme is present at 13 weeks, and
maintains a fairly constant level up to 22 weeks. The fetal liver
(225)has been shown to possess a high rate of glycolysis, which
requires adequate activities of phosphoglucomutase and
phosphoglucoisomerase. From the data in the present study,
neither of these enzymes show activities as high as those
encountered in the normal adult human. They may, however, be
adequate to maintain a fairly high rate of glycolysis. Neither
enzyme shows any change in activity with advancing fetal age in
the period studied, although it may be surmised that a rise in
activity will occur in both enzymes later in gestation, since it
(97 237 243)has been shown that in fetal rats and guinea-pigs ’ ’
both enzymes have reached normal adult levels or higher at the 
end of gestation.
Ten samples of liver from children ranging in age from 6 weeks 
to 10 years 11 months were obtained and the glycogen extracted by 
alkali (Experiment l) or trichloracetic acid (Experiment 2).
The yields of glycogen, given in Table VI, varied from 0*43 to 
5*6%. The purities of the samples were determined by acid 
hydrolysis (Experiment 3)«
TABLE VI
Glycogens obtained from children
Age Fresh wt. 
of sample
% purity 
of
glycogen
wt. of
pure
glycogen
% glycogen 
in liver 
tissue
t 3-28 g. 100 l4'l mg. 0*43
12 wk. 1*09 g. 83-3 19.7 t. 1*81
8 " 43*6 mg. 37*3 1*93 " 4*3
2yr.4m. 234*9 " 98*6 13*2 " 3.6
lyr.8m. 188*6 " 43 1*4 " 0*74
l4 wk. 338*6 " 67*6 4.3 " 1*2
12 " 1*298 g. 69-7 13.9 n 1*2
6 " 30 mg. 43 1*4 " 2*8
lOyr.llm. 302 " 76*6 8*4 " 1.67
7 wk. 366 " 62.3 4.5 ” 0.8
 ^ Extraction of this sample was by potassium hydroxide.
All other extractions were by trichloracetic acid.
The structures of these glycogens were determined by 
^-amylolysis (Experiments 3 and 6) and # -amylolysis (Experiment 10). 
The results (Table VII) show that these glycogens also possess 
average chain lengths in the normal range of 10-14 D-glucose units, 
with the exception of the last sample, which has an average chain 
length of 15*2 D-glucose units. Allowing for the acknowledged 
error of i one D-glucose unit in the method employed (Experiment 10) 
this sample also comes within the normal range.
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TABLE VII
Structures of glycogens from children
Age CL by ECL by 
X-amylase p-amylase
.*. ICL
- 13-6 7-9 4 . 7
12 wk* 13-4 7-9 4-3
8 " 12.6 8.9 2.7
2yr.4m. 12-7 8.6 3*1
lyr.8m . 13-1 9-2 2.9
l4 wk. 13-9 9-3 3*6
12 " 12.9 8.3 3*6
6 " - t -
lOyr.llm. 12-9 8.2 3-7
7 wk. 15-2 9*2 5*0
This 6simple gave 46*5% conversion to maltose.
Five of these samples were treated with concanavalin
(Experiment 25) and their glycogen values measured.
TABLE VIII
Glycogen values determined by the reaction with
concanavalin A.
Age Glycogen
value
2yr. 4m. 0-94 12.7
lyr. 8m. 1.19 13-1
1.03 13.6
12 wk. 0.93 13-4
7 wk. 0.96 13-2
All five values do not differ significantly from unity, 
indicating that they possess structures typical of normal glycogens*
Baboon liver glycogen was extracted by digestion with 
potassium hydroxide, and its purity and structure determined as 
previously described. The value of the average chain length was 
found to be 13*3 D-glucose units both by periodate oxidation and 
o( -amylolysis. The average exterior chain length was found to be 
8*3 D-glucose units, thus giving an average interior chain length 
of 4 D-glucose units. The complex with iodine (Fig II) was found 
to have an absorption maximum at 433 . These results indicate
that baboon liver glycogen has a normal structure. The results 
obtained from the reaction with concanavalin A are more difficult 
to interpret. Baboon liver glycogen has a glycogen value (G.V.) 
of 1*3, while the - and glucamylase-limit dextrins have values 
of 1*74 and 1*12 respectively. The figure obtained for the baboon 
liver glycogen was by far the highest recorded in this study,
(41)
although not outside the normal range, since Smith and coworkers 
have found glycogen values of 1*43 and 3*0 for rabbit hair glycogen 
and baker's yeast glycogen respectively. The glycogen value of 
baboon liver glycogen increased to 1*74 on ^-amylolysis* This is
(4l) (42)in accordance with the results of Smith and Manners.
However, the glucamylase-limit dextrin, while possessing a similar
structure to the j&-limit dextrin, had a lower glycogen value than 
the normal baboon liver glycogen. At present no explanation can 
be advanced for this observation, since the precise nature of the 
reaction between glycogen and concanavalin A is not known, and no 
anomalies have been shown in the structures of these glycogens.
The structures of mouse and rabbit liver glycogens were 
determined as described previously* Mouse liver glycogen was 
found to have a normal structure, its average chain length being 
13*8 D-glucose units by %-amylolysis and 13*1 D-glucose units by 
periodate oxidation. -amylolysis gave an average exterior
chain length of 8.6 D-glucose units, and hence the average interior 
chain length was 3*5 D-glucose units. Further evidence of a 
normal structure was provided by the fact that the glycogen value 
(Experiment 23) was 0*9, and that the iodine complex (Figure II) 
had an absorption maximum at 433 /ryi. Rabbit liver glycogen also 
had a normal structure, having an average chain length of 12*6 
D-glucose units by OC-amylolysis and 13*9 D-glucose units by 
periodate oxidation. The average exterior chain length was found 
to be 8*1 D-glucose units by ^-amylolysis and hence the average 
interior chain length was 4*2 D-glucose units. The absorption 
maximum of the iodine complex was 4 ? 0 ^ ^  (Figure II), which is 
within the normal range.
(b) Studies on hospital cases 
Four samples of human liver were obtained from cases of 
suspected glycogen storage disease, and their structures determined 
by the methods described in Experiment 4l.
Patient P.M. was subject to fits and his physical development 
was somewhat retarded. He was found to be hypoglycaemic and, at 
laparotomy, islet cell hyperplasia of the pancreas was discovered. 
Glycogen from a sample of liver obtained at laparotomy was found 
to have a normal structure. The average chain length was found 
to be 12*5 D-glucose units by ^-amylolysis, and ^-amylolysis 
gave a value of 8*2 D-glucose units for the average exterior chain 
length, and hence an average interior chain length of 3*3 D-glucose 
units. Later it was found that L-leucine caused the 
hypoglycaemia* The latter could be controlled by a diet low in 
L-leucine, thus ruling out the possibility that the hypoglycaemia 
was caused by glycogen storage disease*
Patient D.H. had an enlarged liver and although at first she 
was small and underweight, she soon began to put on weight rapidly. 
A histological examination of the liver had shown some accumulation 
of glycogen and fat and normal levels of glucose-6-phosphatase and 
phosphorylase. The response to glucagon was normal, supporting 
the histological evidence for the presence of glucose-6-phosphatase,
^7
Glycogen storage disease had been suggested as a possible
explanation. The glycogen obtained from a biopsy specimen was
found to have a structure a little more compact than any that had
(25)been encountered in human specimens. The average chain length
was 10*5 D-glucose units and the average exterior chain length 
6*8 D-glucose units, giving an average interior chain length of 
2*7 D-glucose units. The average chain length was 2 D-glucose 
units lower than other human glycogens. This result may not be 
significant, since the method employed for the determination of the 
average chain length is accurate only to ± one D-glucose unit, and
the ECL:ICL ratio was approximately 2:1, indicating normal branching 
characteristics. Also the absorption maximum of the complex with 
iodine was 450 royu, (Figure III), which was well within the range 
normally encountered. As yet, no definite diagnosis has been made 
on the patient, who remains fairly well.
Patient J.H. was also found to have an enlarged liver*
She was hypoglycaemic and had a poor response to adrenaline and 
D-fructose, but a fairly good response to intravenous injection 
of glucagon* Histological examination had shown a large 
accumulation of glycogen and fat, and a low activity of glucose-6- 
phosphatase and branching enzyme* The structure of the glycogen 
was found to be a rather open one* The average chain length was
/^hsorpiüorL sp-ecérvL o f  -  (oc( 'c/7e
corrjplexes
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16 p-glucose units and the average exterior chain length 10*8 
D-glucose units, giving an average interior chain length of 
4*2 D-glucose units. It is possible that a slight deficiency of 
branching enzyme could produce a structure such as this. No 
normal human glycogen has been reported to possess such a high 
average chain length, although several horse and ox muscle glycogens 
with average chain lengths of up to 1? D-glucose units are known.
In view of this it cannot be stated definitely that the high average 
chain length is caused by branching enzyme deficiency. The 
absorption maximum of the glycogen-iodine complex (Figure III) was 
425wyc 1 which indicates that the structure of the glycogen is a 
normal one. The glycogen value of 0*96 found from the reaction 
with concanavalin A (Experiment 25) provides additional evidence 
for a normal structure.
Patient S.L. died in hepatic failure and the liver sample was 
obtained at autopsy. This patient had been previously investigated 
in hospital, where it was found that the glycogen content of the 
liver was abnormally high. From a study of the iodine complex and 
the degradation by %-amylase, it was originally concluded that the 
glycogen had a high degree of branching, and, therefore, a 
deficiency of debranching enzyme. Glucose-6-phosphatase activity 
was stated to be normal.
The present findings are completely at variance with this.
The structure of the glycogen appears to be almost identical with 
that of patient J.H. The average chain length was found to be 
16.5 D-glucose units by oc-amylolysis and 15*9 D-glucose units by 
periodate oxidation. The average exterior chain length was found 
to be 11*0 D-glucose units by ^-amylolysis, giving an average 
interior chain length of 4*2 D-glucose units. As with patient 
J.H., it is uncertain whether this structure is the result of a 
slight branching enzyme deficiency. One striking difference 
between the glycogens from patients J.H. and S.L. occurs in their 
reaction with iodine. The iodine complex with J.H. glycogen has 
an absorption maximum at 425^^ , whereas the complex with S.L. 
glycogen has its absorption maximum at 480wyiA, despite the almost 
identical structures of the two glycogens. Obviously the value 
of the absorption maximum is not always an infallible guide to the 
structure of the glycogen.
Patient G.B. was a young baby who failed to gain in weight 
almost from birth, and was found to be unable to metabolise lactose 
or sucrose in the intestine. Accordingly milk was omitted from 
his diet. When arrowroot.or rice was included as the 
carbohydrate source, urine samples were found to contain a 
reducing sugar very similar to lactose in its behaviour on
9/
chromatography in ethyl acetate: pyridine : water (10:4:3) solvent, 
although it was not hydrolysed by lactase ( jh -D-galactoside 
galactohydrolase) . Chromatographic examination of urine 
samples in solvents I, II, III and IV (Experiment 30) failed to 
elucidate the nature of the unknown sugar, since its "Rf value 
in all four solvents was identical with that of lactose. The 
mobilities of the unknown sugar and its reduced form, when subjected 
to paper electrophoresis (Experiments 31 and 32), corresponded to 
those of isomaltose and isomaltitol respectively. Separation of 
the reducing sugar from the urine, followed by hydrolysis, revealed 
glucose as the only sugar present (Experiment 34). From this 
evidence it can be concluded that the unknown sugar was isomaltose.
The isomaltose probably arises from the (X-(l--^ 6)-linked D-glucose 
units in amylopectin, which constitutes 81*5% of rice starch and 
79*3% of arrowroot. Thus besides lacking the enzymes, which 
hydrolyse sucrose and lactose, the patient was also appreciably 
deficient in isomaltase (isomaltose 6-glucohydrolase)• When 
amylose was substituted for arrowroot or rice, thus removing the 
source of (\-(/—> 6)-linked D-glucose units, the patient's condition 
improved. He gained a few pounds in weight and no more isomaltose 
could be detected in the urine. At this stage a preparation of 
milk, treated with lactase to remove the lactose, was included in 
the diet, and the urine samples collected then showed the presence 
of two sugars with values slightly less than lactose in solvent II
9^
(ethyl acetate : pyridine : water, 10:4:3)* The same or similar 
sugars were found to be present in the lactose-reduced milk.^^^^^ 
When samples C (lactose-reduced milk) and D (urine taken when the 
patient was fed on a diet containing lactose-reduced milk and 
amylose) were examined as described in Experiments 35 to 37» it 
was found that both the unknown sugars contained glucose and 
galactose, and from their chromatographic behaviour were most 
probably disaccharides. The reduced forms streaked badly when 
examined by paper electrophoresis in molybdate buffer and no 
accurate deductions could be made about the linkages. However, 
it is fairly certain that the sugars appearing in the urine are 
the same as those present in the lactose-reduced milk. They are 
probably formed by transglycosylation:
Gal 1 4 Glue :^==~==~± Enzyme-Gal + Glue
7>
Enzyme-Gal + Glue Gal 1 ? Glue + Enzyme
The patient is unable to metabolise these new products, indicating 
the lack of yet another enzyme. The presence of these sugars 
appear to contribute to the patient's lack of progress and it would 
be advantageous to find a method of removing them from the milk. 
This is at present being investigated at Royal Holloway College.
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(c) Studies on glucamylase 
The action of glucamylase on rabbit liver glycogen was 
complete after 26 hr. (Experiment 12) and resulted in the production 
of 54*5% D-glucose. The production of maltose from p-amylase 
action on rabbit liver glycogen was 46*8%. Assuming that 
p-amylase leaves stubs on an average length of 2*5 D-glucose
/ O p  \
units, the figure for the action of glucamylase shows that
this enzyme leaves stubs of average length 1*5 D-glucose units. 
Incubation of rabbit liver glycogen with ^-amylase, followed by 
incubation with glucamylase (Experiment 15) resulted in a final 
production of D-glucose of 60*2%, indicating that stubs of average 
length of 1 D-glucose unit were left after glucamylase action. 
Periodate oxidation (Experiments l6 and 17» Figure IV) of the limit 
dextrins isolated after ^-amylase (Experiment l4) and 
glucamylase (Experiment 15) action gave average chain lengths of 
7*2 D-glucose units for the -limit dextrin and 6*0 D-glucose 
units for the glucamylase-limit dextrin. The corresponding values 
determined by CK-amylolysis were 7*5 and 6*5 D-glucose units 
respectively. From the above data it appears that glucamylase 
removes an average of one p-glucose unit more than jS-amylase, 
leaving stubs of average chain length 1*5 D-glucose units. These 
stubs would consist of either single p-glucose units or maltose 
units, linked to the rest of the molecule by an û^-(l-->6)-linkage. 
In Experiment 15 the incubation with glucamylase was a prolonged
one of 5 days. If left for this length of time, the enzyme 
appears to reduce all the stubs to one D-glucose unit in length, 
but does not attack the branch linkages.
A - Structure of glucamylase-limit dextrin after 1-2 days* 
incubation with glucamylase
B - Structure of the dextrin after 5 days' incubation 
The amount of degradation caused by the Aspergillus 
amyloglucosidases varies with the species and even among the 
same species. Preparations from ^  oryzae , for example, 
effect a 100% conversion to D-glucose, whereas various preparations 
from ^  niger result in 50-60% or 100% (107,108)
conversions to D-glucose* The complete hydrolysis caused by 
these enzymes is not due to contamination by #-amylase, since 
careful steps have been taken to remove this impurity* It appears 
that most of the pure enzyme preparations are capable of hydrolysing 
both and ik'-(l— 9-6)- D-glucosidic linkages, the
A. niger preparations by Barker and Fleetwood (100*106) Kerr
9^
and coworkers (1^1^ being the only exceptions. These workers 
have prepared enzymes with almost negligible action on ^-(1— >6)- 
glucosidic linkages. Using Barker and Fleetwood's chromatographic 
method for purification, the "Diazyme” preparation used by Pazur 
and Ando d07,108) separated into two amylolytic fractions
(Experiment 21), corresponding to those isolated by Barker and 
F l e e t w o o d . H o w e v e r ,  on incubation with glycogen (Experiment 22), 
both fractions produced complete hydrolysis to D-glucose, showing 
that no separation of ^-(1 -:^4)- and (3(r-(l-^6)- glucosidase 
activities had been achieved* Using a laboratory-grown culture 
of ^  niger NRRL-330-1, the method resulted in the separation of a 
fraction containing only 0(-(l— :^4)- glucosidase activity.
From these results it is concluded that the pure /^-glucosidase 
in "Diazyme" is not so specific as that obtainable from ^  niger 
NRRL-330-1, prepared by the method of Barker and Fleetwood.
The reason for the difference in specificity between the two 
enzyme preparations is not clear. The ^  niger strain used in 
the preparation of "Diazyme" was not specified, neither were the 
constituents of its culture medium. Both these factors may be 
important in influencing the enzyme specificity. In this context 
it is perhaps significant to note that Kerr and coworkers 
and Barker and Fleetwood used the same strain of ^  niger
and are the only workers who have obtained a preparation with no 
action on ^-(l -^6)-linkages.
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The inclusion of some compounds into culture media is known 
to stimulate the production in moulds and bacteria of enzymes 
capable of utilising these compounds as s u b s t r a t e s . T h i s  is 
known as enzyme induction* Inclusion of such compounds as 
isomaltose or dextran into the ^  niger culture medium would 
conceivably cause a modification of the amyloglucosidase in this 
manner.
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